# IBM timeline

entity: /record/ibm.md  
id: ent_ibm  

IBM's timeline holds 780 claims from 1911 to 2026: 12 people, 489 money & deals, 6 products, 1 models, 272 other. 21 are undated. The latest took effect on November 6, 2026.

Kinds: People 12 (/timelines/ibm.md?kind=people) · Money & deals 489 (/timelines/ibm.md?kind=money) · Products 6 (/timelines/ibm.md?kind=products) · Models 1 (/timelines/ibm.md?kind=models) · Other 272 (/timelines/ibm.md?kind=other)  
Format: date | kind | predicate | value | status | claim.

## 1911

- 1911-06-16 | other | founded | 1911-06-16 | valid | [clm_187456D03C18](/claim/clm_187456D03C18.md)

## 2006

- 2006-12-31 to 2007-12-31 | money | cash_and_equivalents | 8,022,000,000 United States dollar | superseded | [clm_BF5A9080E26F](/claim/clm_BF5A9080E26F.md)
- 2006-12-31 to 2007-12-31 | money | total_equity | 28,635,000,000 United States dollar | superseded | [clm_C0921001FED6](/claim/clm_C0921001FED6.md)

## 2007

- 2007-12-31 to 2008-06-30 | money | cash_and_equivalents | 14,991,000,000 United States dollar | superseded | [clm_6D974FB350C5](/claim/clm_6D974FB350C5.md)
- 2007-12-31 to 2008-12-31 | money | research_and_development | 6,153,000,000 United States dollar | superseded | [clm_C93A1A76F422](/claim/clm_C93A1A76F422.md)
- 2007-12-31 to 2008-12-31 | money | revenue | 98,786,000,000 United States dollar | superseded | [clm_FCE452A5B402](/claim/clm_FCE452A5B402.md)
- 2007-12-31 to 2008-12-31 | money | total_equity | 28,615,000,000 United States dollar | superseded | [clm_798CB57FCCA3](/claim/clm_798CB57FCCA3.md)

## 2008

- 2008-06-30 to 2008-09-30 | money | cash_and_equivalents | 9,626,000,000 United States dollar | superseded | [clm_9A068A6C5E0C](/claim/clm_9A068A6C5E0C.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_research_and_development | 1,660,000,000 United States dollar | superseded | [clm_B1632FA941A6](/claim/clm_B1632FA941A6.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_revenue | 26,820,000,000 United States dollar | superseded | [clm_A1B73A25FAFD](/claim/clm_A1B73A25FAFD.md)
- 2008-09-30 to 2008-12-31 | money | cash_and_equivalents | 9,755,000,000 United States dollar | superseded | [clm_89C491869173](/claim/clm_89C491869173.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_research_and_development | 1,579,000,000 United States dollar | superseded | [clm_2B7C2E91D29F](/claim/clm_2B7C2E91D29F.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_revenue | 25,302,000,000 United States dollar | superseded | [clm_304B907BB058](/claim/clm_304B907BB058.md)
- 2008-12-31 to 2009-03-31 | money | cash_and_equivalents | 12,741,000,000 United States dollar | superseded | [clm_E2320DC9B5AE](/claim/clm_E2320DC9B5AE.md)
- 2008-12-31 to 2009-12-31 | money | research_and_development | 6,337,000,000 United States dollar | superseded | [clm_B604752587B0](/claim/clm_B604752587B0.md)
- 2008-12-31 to 2009-12-31 | money | revenue | 103,630,000,000 United States dollar | superseded | [clm_F53E8B999A5D](/claim/clm_F53E8B999A5D.md)
- 2008-12-31 to 2009-06-30 | money | total_assets | 109,524,000,000 United States dollar | superseded | [clm_83EB704E3714](/claim/clm_83EB704E3714.md)
- 2008-12-31 to 2009-06-30 | money | total_equity | 13,465,000,000 United States dollar | superseded | [clm_19C8D0A5561E](/claim/clm_19C8D0A5561E.md)

## 2009

- 2009-03-31 to 2009-06-30 | money | cash_and_equivalents | 12,294,000,000 United States dollar | superseded | [clm_ABE90E51CBC5](/claim/clm_ABE90E51CBC5.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_research_and_development | 1,480,000,000 United States dollar | superseded | [clm_713D609DB0D0](/claim/clm_713D609DB0D0.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_revenue | 21,711,000,000 United States dollar | superseded | [clm_89CCF5E1D94C](/claim/clm_89CCF5E1D94C.md)
- 2009-06-30 to 2009-09-30 | money | cash_and_equivalents | 11,678,000,000 United States dollar | superseded | [clm_2DFFF296FE3F](/claim/clm_2DFFF296FE3F.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_research_and_development | 1,434,000,000 United States dollar | superseded | [clm_D7D908173FEA](/claim/clm_D7D908173FEA.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_revenue | 23,250,000,000 United States dollar | superseded | [clm_98BC46C0F1BB](/claim/clm_98BC46C0F1BB.md)
- 2009-06-30 to 2009-09-30 | money | shares_outstanding | 1,310,883,577 shares | superseded | [clm_1CB85614F696](/claim/clm_1CB85614F696.md)
- 2009-06-30 to 2009-09-30 | money | total_assets | 103,655,000,000 United States dollar | superseded | [clm_451FE09C5795](/claim/clm_451FE09C5795.md)
- 2009-06-30 to 2009-09-30 | money | total_equity | 15,380,000,000 United States dollar | superseded | [clm_F02C6F57DFF7](/claim/clm_F02C6F57DFF7.md)
- 2009-09-30 to 2009-12-31 | money | cash_and_equivalents | 9,532,000,000 United States dollar | superseded | [clm_5B0309CB82D7](/claim/clm_5B0309CB82D7.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_research_and_development | 1,446,000,000 United States dollar | superseded | [clm_59F0F4B2567C](/claim/clm_59F0F4B2567C.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_revenue | 23,566,000,000 United States dollar | superseded | [clm_D4C36FEED8BE](/claim/clm_D4C36FEED8BE.md)
- 2009-09-30 to 2010-02-10 | money | shares_outstanding | 1,313,602,936 shares | superseded | [clm_95E012210E6E](/claim/clm_95E012210E6E.md)
- 2009-09-30 to 2009-12-31 | money | total_assets | 103,675,000,000 United States dollar | superseded | [clm_09B9AA0C7DF6](/claim/clm_09B9AA0C7DF6.md)
- 2009-09-30 to 2009-12-31 | money | total_equity | 18,396,000,000 United States dollar | superseded | [clm_92CA36DBD0C3](/claim/clm_92CA36DBD0C3.md)
- 2009-12-31 to 2010-03-31 | money | cash_and_equivalents | 12,183,000,000 United States dollar | superseded | [clm_2CE2E631C4E6](/claim/clm_2CE2E631C4E6.md)
- 2009-12-31 to 2010-12-31 | money | research_and_development | 5,820,000,000 United States dollar | superseded | [clm_4AB191EB2E7E](/claim/clm_4AB191EB2E7E.md)
- 2009-12-31 to 2010-12-31 | money | revenue | 95,758,000,000 United States dollar | superseded | [clm_503CBB23BC36](/claim/clm_503CBB23BC36.md)
- 2009-12-31 to 2010-03-31 | money | total_assets | 109,022,000,000 United States dollar | superseded | [clm_E39700340813](/claim/clm_E39700340813.md)
- 2009-12-31 to 2010-03-31 | money | total_equity | 22,637,000,000 United States dollar | superseded | [clm_EB3880812770](/claim/clm_EB3880812770.md)

## 2010

- 2010-02-10 to 2010-03-31 | money | shares_outstanding | 1,299,003,390 shares | superseded | [clm_AD7E53D06590](/claim/clm_AD7E53D06590.md)
- 2010-03-31 to 2010-06-30 | money | cash_and_equivalents | 12,472,000,000 United States dollar | superseded | [clm_0F128E5C857F](/claim/clm_0F128E5C857F.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_research_and_development | 1,509,000,000 United States dollar | superseded | [clm_E216563C5E20](/claim/clm_E216563C5E20.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_revenue | 22,857,000,000 United States dollar | superseded | [clm_F39295E2D29D](/claim/clm_F39295E2D29D.md)
- 2010-03-31 to 2010-09-30 | money | shares_outstanding | 1,282,347,653 shares | superseded | [clm_C558CBF3059C](/claim/clm_C558CBF3059C.md)
- 2010-03-31 to 2010-06-30 | money | total_assets | 105,208,000,000 United States dollar | superseded | [clm_001245DE8234](/claim/clm_001245DE8234.md)
- 2010-03-31 to 2010-06-30 | money | total_equity | 22,033,000,000 United States dollar | superseded | [clm_8AAD25E63B16](/claim/clm_8AAD25E63B16.md)
- 2010-06-30 to 2010-09-30 | money | cash_and_equivalents | 10,325,000,000 United States dollar | superseded | [clm_D6F655867CDB](/claim/clm_D6F655867CDB.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_research_and_development | 1,475,000,000 United States dollar | superseded | [clm_C8EA68897F5D](/claim/clm_C8EA68897F5D.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_revenue | 23,724,000,000 United States dollar | superseded | [clm_125CA4A00837](/claim/clm_125CA4A00837.md)
- 2010-06-30 to 2010-09-30 | money | total_assets | 103,420,000,000 United States dollar | superseded | [clm_0DDE538787A5](/claim/clm_0DDE538787A5.md)
- 2010-06-30 to 2010-09-30 | money | total_equity | 21,059,000,000 United States dollar | superseded | [clm_6FDC5F2DEC7B](/claim/clm_6FDC5F2DEC7B.md)
- 2010-09-30 to 2010-12-31 | money | cash_and_equivalents | 9,859,000,000 United States dollar | superseded | [clm_8845DFDA27C2](/claim/clm_8845DFDA27C2.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_research_and_development | 1,464,000,000 United States dollar | superseded | [clm_34120A85629D](/claim/clm_34120A85629D.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_revenue | 24,271,000,000 United States dollar | superseded | [clm_971948FFCAFA](/claim/clm_971948FFCAFA.md)
- 2010-09-30 to 2011-01-31 | money | shares_outstanding | 1,242,361,137 shares | superseded | [clm_7E4F237B5FC0](/claim/clm_7E4F237B5FC0.md)
- 2010-09-30 to 2010-12-31 | money | total_assets | 107,174,000,000 United States dollar | superseded | [clm_72B0F1AF4111](/claim/clm_72B0F1AF4111.md)
- 2010-09-30 to 2010-12-31 | money | total_equity | 22,238,000,000 United States dollar | superseded | [clm_196B2C574231](/claim/clm_196B2C574231.md)
- 2010-12-31 to 2011-03-31 | money | cash_and_equivalents | 10,661,000,000 United States dollar | superseded | [clm_B54D0382FE39](/claim/clm_B54D0382FE39.md)
- 2010-12-31 to 2011-12-31 | money | research_and_development | 6,026,000,000 United States dollar | superseded | [clm_E10D7E9603C8](/claim/clm_E10D7E9603C8.md)
- 2010-12-31 to 2011-12-31 | money | revenue | 99,870,000,000 United States dollar | superseded | [clm_70C7FB5344C0](/claim/clm_70C7FB5344C0.md)
- 2010-12-31 to 2011-03-31 | money | total_assets | 113,452,000,000 United States dollar | superseded | [clm_C15669FC6D86](/claim/clm_C15669FC6D86.md)
- 2010-12-31 to 2011-03-31 | money | total_equity | 23,046,000,000 United States dollar | superseded | [clm_6ED6A2DE96EC](/claim/clm_6ED6A2DE96EC.md)

## 2011

- 2011-01-31 to 2011-03-31 | money | shares_outstanding | 1,219,536,250 shares | superseded | [clm_3EA54DF77456](/claim/clm_3EA54DF77456.md)
- 2011-03-31 to 2011-06-30 | money | cash_and_equivalents | 12,763,000,000 United States dollar | superseded | [clm_9ADAE4DD887F](/claim/clm_9ADAE4DD887F.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_research_and_development | 1,587,000,000 United States dollar | superseded | [clm_904728A0807C](/claim/clm_904728A0807C.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_revenue | 24,607,000,000 United States dollar | superseded | [clm_6741079A02E3](/claim/clm_6741079A02E3.md)
- 2011-03-31 to 2011-06-30 | money | shares_outstanding | 1,211,200,200 shares | superseded | [clm_513A66D8B56A](/claim/clm_513A66D8B56A.md)
- 2011-03-31 to 2011-06-30 | money | total_assets | 112,960,000,000 United States dollar | superseded | [clm_24C5ED65CE76](/claim/clm_24C5ED65CE76.md)
- 2011-03-31 to 2011-06-30 | money | total_equity | 22,671,000,000 United States dollar | superseded | [clm_14A3403B6C49](/claim/clm_14A3403B6C49.md)
- 2011-06-30 to 2011-09-30 | money | cash_and_equivalents | 11,714,000,000 United States dollar | superseded | [clm_62A4DDC19B20](/claim/clm_62A4DDC19B20.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_research_and_development | 1,569,000,000 United States dollar | superseded | [clm_68BFD8FAE8D2](/claim/clm_68BFD8FAE8D2.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_revenue | 26,666,000,000 United States dollar | superseded | [clm_AE94716C8789](/claim/clm_AE94716C8789.md)
- 2011-06-30 to 2011-09-30 | money | shares_outstanding | 1,194,278,216 shares | superseded | [clm_D5837CF00778](/claim/clm_D5837CF00778.md)
- 2011-06-30 to 2011-09-30 | money | total_assets | 113,474,000,000 United States dollar | superseded | [clm_87B8019AD4AA](/claim/clm_87B8019AD4AA.md)
- 2011-06-30 to 2011-09-30 | money | total_equity | 23,127,000,000 United States dollar | superseded | [clm_CE78213432D0](/claim/clm_CE78213432D0.md)
- 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 11,303,000,000 United States dollar | superseded | [clm_6E053BBA66BD](/claim/clm_6E053BBA66BD.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_research_and_development | 1,546,000,000 United States dollar | superseded | [clm_7DD62EAF9FF1](/claim/clm_7DD62EAF9FF1.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_revenue | 26,157,000,000 United States dollar | superseded | [clm_8ED420456E05](/claim/clm_8ED420456E05.md)
- 2011-09-30 to 2012-01-31 | money | shares_outstanding | 1,178,618,168 shares | superseded | [clm_34482D0F9770](/claim/clm_34482D0F9770.md)
- 2011-09-30 to 2011-12-31 | money | total_assets | 110,158,000,000 United States dollar | superseded | [clm_81F85B61BA93](/claim/clm_81F85B61BA93.md)
- 2011-09-30 to 2011-12-31 | money | total_equity | 22,291,000,000 United States dollar | superseded | [clm_57B7F256D3DB](/claim/clm_57B7F256D3DB.md)
- 2011-12-31 to 2012-03-31 | money | cash_and_equivalents | 11,922,000,000 United States dollar | superseded | [clm_290BE6F8F242](/claim/clm_290BE6F8F242.md)
- 2011-12-31 to 2012-12-31 | money | research_and_development | 6,258,000,000 United States dollar | superseded | [clm_71088A6EDE70](/claim/clm_71088A6EDE70.md)
- 2011-12-31 to 2012-12-31 | money | revenue | 106,916,000,000 United States dollar | superseded | [clm_6B920BB879F4](/claim/clm_6B920BB879F4.md)
- 2011-12-31 to 2012-03-31 | money | total_assets | 116,433,000,000 United States dollar | superseded | [clm_54E0086BE0B1](/claim/clm_54E0086BE0B1.md)
- 2011-12-31 to 2012-03-31 | money | total_equity | 20,138,000,000 United States dollar | superseded | [clm_06B4B31F3760](/claim/clm_06B4B31F3760.md)

## 2012

- 2012-01-01 to 2020-04-01 | people | ceo | [Ginni Rometty](/record/ginni-rometty.md) | superseded | [clm_1586FBF805E5](/claim/clm_1586FBF805E5.md)
- 2012-01-31 to 2012-03-31 | money | shares_outstanding | 1,158,661,712 shares | superseded | [clm_85A8E4E85DFB](/claim/clm_85A8E4E85DFB.md)
- 2012-03-31 to 2012-06-30 | money | cash_and_equivalents | 11,835,000,000 United States dollar | superseded | [clm_157B24138303](/claim/clm_157B24138303.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_research_and_development | 1,601,000,000 United States dollar | superseded | [clm_32C1B83DDF4D](/claim/clm_32C1B83DDF4D.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_revenue | 24,673,000,000 United States dollar | superseded | [clm_B54D3800ED40](/claim/clm_B54D3800ED40.md)
- 2012-03-31 to 2012-06-30 | money | shares_outstanding | 1,153,484,394 shares | superseded | [clm_D4EB7D8150FC](/claim/clm_D4EB7D8150FC.md)
- 2012-03-31 to 2012-06-30 | money | total_assets | 115,347,000,000 United States dollar | superseded | [clm_C9FA243BB148](/claim/clm_C9FA243BB148.md)
- 2012-03-31 to 2012-06-30 | money | total_equity | 20,701,000,000 United States dollar | superseded | [clm_4C4410597455](/claim/clm_4C4410597455.md)
- 2012-06-30 to 2012-09-30 | money | cash_and_equivalents | 10,864,000,000 United States dollar | superseded | [clm_E383791D627A](/claim/clm_E383791D627A.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_research_and_development | 1,587,000,000 United States dollar | superseded | [clm_E988625CACD2](/claim/clm_E988625CACD2.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_revenue | 25,783,000,000 United States dollar | superseded | [clm_40454B8D7391](/claim/clm_40454B8D7391.md)
- 2012-06-30 to 2012-09-30 | money | shares_outstanding | 1,142,774,594 shares | superseded | [clm_F971F0B6CF89](/claim/clm_F971F0B6CF89.md)
- 2012-06-30 to 2012-09-30 | money | total_assets | 113,832,000,000 United States dollar | superseded | [clm_164B25AC7631](/claim/clm_164B25AC7631.md)
- 2012-06-30 to 2012-09-30 | money | total_equity | 20,472,000,000 United States dollar | superseded | [clm_1C651F03CC3B](/claim/clm_1C651F03CC3B.md)
- 2012-09-30 to 2012-12-31 | money | cash_and_equivalents | 11,909,000,000 United States dollar | superseded | [clm_123FFAE54401](/claim/clm_123FFAE54401.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_research_and_development | 1,534,000,000 United States dollar | superseded | [clm_653CF786F5CF](/claim/clm_653CF786F5CF.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_revenue | 24,747,000,000 United States dollar | superseded | [clm_0988A40F3C20](/claim/clm_0988A40F3C20.md)
- 2012-09-30 to 2013-01-31 | money | shares_outstanding | 1,129,932,457 shares | superseded | [clm_0FE7DF146F95](/claim/clm_0FE7DF146F95.md)
- 2012-09-30 to 2012-12-31 | money | total_assets | 115,778,000,000 United States dollar | superseded | [clm_932C08EBC709](/claim/clm_932C08EBC709.md)
- 2012-09-30 to 2012-12-31 | money | total_equity | 21,541,000,000 United States dollar | superseded | [clm_26339EEDCB15](/claim/clm_26339EEDCB15.md)
- 2012-10-01 to 2021-01-01 | people | chair | [Ginni Rometty](/record/ginni-rometty.md) | superseded | [clm_9C399CAEE51C](/claim/clm_9C399CAEE51C.md)
- 2012-12-31 to 2013-03-31 | money | cash_and_equivalents | 10,412,000,000 United States dollar | superseded | [clm_EA1C246D8041](/claim/clm_EA1C246D8041.md)
- 2012-12-31 to 2013-12-31 | money | research_and_development | 6,302,000,000 United States dollar | superseded | [clm_65BAC2087D8D](/claim/clm_65BAC2087D8D.md)
- 2012-12-31 to 2013-12-31 | money | revenue | 104,507,000,000 United States dollar | superseded | [clm_984735C65BEA](/claim/clm_984735C65BEA.md)
- 2012-12-31 to 2013-03-31 | money | total_assets | 119,213,000,000 United States dollar | superseded | [clm_6E27098AA3F0](/claim/clm_6E27098AA3F0.md)
- 2012-12-31 to 2013-03-31 | money | total_equity | 18,860,000,000 United States dollar | superseded | [clm_0753895DCDD1](/claim/clm_0753895DCDD1.md)

## 2013

- 2013-01-31 to 2013-03-31 | money | shares_outstanding | 1,114,509,771 shares | superseded | [clm_B85EB55A461B](/claim/clm_B85EB55A461B.md)
- 2013-03-31 to 2013-06-30 | money | cash_and_equivalents | 10,585,000,000 United States dollar | superseded | [clm_21F09B1CA5BD](/claim/clm_21F09B1CA5BD.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_research_and_development | 1,644,000,000 United States dollar | superseded | [clm_F754E3363720](/claim/clm_F754E3363720.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_revenue | 23,408,000,000 United States dollar | superseded | [clm_8D8AA58B6911](/claim/clm_8D8AA58B6911.md)
- 2013-03-31 to 2013-06-30 | money | shares_outstanding | 1,108,794,396 shares | superseded | [clm_8005CC32DC0E](/claim/clm_8005CC32DC0E.md)
- 2013-03-31 to 2013-06-30 | money | total_assets | 117,258,000,000 United States dollar | superseded | [clm_08BD488B2A33](/claim/clm_08BD488B2A33.md)
- 2013-03-31 to 2013-06-30 | money | total_equity | 19,092,000,000 United States dollar | superseded | [clm_8B156B7C3845](/claim/clm_8B156B7C3845.md)
- 2013-06-30 to 2013-09-30 | money | cash_and_equivalents | 9,558,000,000 United States dollar | superseded | [clm_3A6B1B19ACD6](/claim/clm_3A6B1B19ACD6.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_research_and_development | 1,548,000,000 United States dollar | superseded | [clm_C36DA52A3657](/claim/clm_C36DA52A3657.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_revenue | 24,924,000,000 United States dollar | superseded | [clm_4D59DA65ADAB](/claim/clm_4D59DA65ADAB.md)
- 2013-06-30 to 2013-09-30 | money | shares_outstanding | 1,095,425,823 shares | superseded | [clm_36F194ED7B1E](/claim/clm_36F194ED7B1E.md)
- 2013-06-30 to 2013-09-30 | money | total_assets | 115,153,000,000 United States dollar | superseded | [clm_AA52C15BC80C](/claim/clm_AA52C15BC80C.md)
- 2013-06-30 to 2013-09-30 | money | total_equity | 17,756,000,000 United States dollar | superseded | [clm_57E825B0167A](/claim/clm_57E825B0167A.md)
- 2013-09-30 to 2013-12-31 | money | cash_and_equivalents | 10,072,000,000 United States dollar | superseded | [clm_813583E22F56](/claim/clm_813583E22F56.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_research_and_development | 1,468,000,000 United States dollar | superseded | [clm_C0FAD4460DCC](/claim/clm_C0FAD4460DCC.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_revenue | 23,720,000,000 United States dollar | superseded | [clm_2941CA813020](/claim/clm_2941CA813020.md)
- 2013-09-30 to 2014-02-10 | money | shares_outstanding | 1,085,854,383 shares | superseded | [clm_86127DDE904A](/claim/clm_86127DDE904A.md)
- 2013-09-30 to 2013-12-31 | money | total_assets | 117,845,000,000 United States dollar | superseded | [clm_63071C5833D3](/claim/clm_63071C5833D3.md)
- 2013-09-30 to 2013-12-31 | money | total_equity | 19,877,000,000 United States dollar | superseded | [clm_3EC4E73747F0](/claim/clm_3EC4E73747F0.md)
- 2013-12-31 to 2014-03-31 | money | cash_and_equivalents | 10,716,000,000 United States dollar | superseded | [clm_790AB47D9D16](/claim/clm_790AB47D9D16.md)
- 2013-12-31 to 2014-12-31 | money | research_and_development | 6,226,000,000 United States dollar | superseded | [clm_ED349B046505](/claim/clm_ED349B046505.md)
- 2013-12-31 to 2014-12-31 | money | revenue | 99,751,000,000 United States dollar | superseded | [clm_74F0D54CDE8C](/claim/clm_74F0D54CDE8C.md)
- 2013-12-31 to 2014-03-31 | money | total_assets | 126,223,000,000 United States dollar | superseded | [clm_19FC388D03A3](/claim/clm_19FC388D03A3.md)
- 2013-12-31 to 2014-03-31 | money | total_equity | 22,792,000,000 United States dollar | superseded | [clm_1FB0603B93AD](/claim/clm_1FB0603B93AD.md)

## 2014

- 2014-01-01 | people | board_member | [Alex Gorsky](/record/alex-gorsky.md) | valid | [clm_5FF0942456FD](/claim/clm_5FF0942456FD.md)
- 2014-02-10 to 2014-03-31 | money | shares_outstanding | 1,041,340,758 shares | superseded | [clm_081605DF2EF5](/claim/clm_081605DF2EF5.md)
- 2014-03-31 to 2014-06-30 | money | cash_and_equivalents | 9,409,000,000 United States dollar | superseded | [clm_DEEF89F226E0](/claim/clm_DEEF89F226E0.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_research_and_development | 1,501,000,000 United States dollar | superseded | [clm_9944F45BE302](/claim/clm_9944F45BE302.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_revenue | 22,484,000,000 United States dollar | superseded | [clm_E0506AB8967D](/claim/clm_E0506AB8967D.md)
- 2014-03-31 to 2014-06-30 | money | shares_outstanding | 1,012,183,432 shares | superseded | [clm_DCF60F6232F5](/claim/clm_DCF60F6232F5.md)
- 2014-03-31 to 2014-06-30 | money | total_assets | 122,646,000,000 United States dollar | superseded | [clm_D4DEAD354DF6](/claim/clm_D4DEAD354DF6.md)
- 2014-03-31 to 2014-06-30 | money | total_equity | 16,607,000,000 United States dollar | superseded | [clm_486AC6396E40](/claim/clm_486AC6396E40.md)
- 2014-06-30 to 2014-09-30 | money | cash_and_equivalents | 9,715,000,000 United States dollar | superseded | [clm_F381553C9E24](/claim/clm_F381553C9E24.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_research_and_development | 1,457,000,000 United States dollar | superseded | [clm_F72782AE3232](/claim/clm_F72782AE3232.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_revenue | 24,364,000,000 United States dollar | superseded | [clm_81C068D41D76](/claim/clm_81C068D41D76.md)
- 2014-06-30 to 2014-09-30 | money | shares_outstanding | 997,592,162 shares | superseded | [clm_BF68514C74C6](/claim/clm_BF68514C74C6.md)
- 2014-06-30 to 2014-09-30 | money | total_assets | 124,314,000,000 United States dollar | superseded | [clm_C6EB3A0B96FC](/claim/clm_C6EB3A0B96FC.md)
- 2014-06-30 to 2014-09-30 | money | total_equity | 17,377,000,000 United States dollar | superseded | [clm_F9ACEC729C2A](/claim/clm_F9ACEC729C2A.md)
- 2014-09-30 to 2014-12-31 | money | cash_and_equivalents | 9,561,000,000 United States dollar | superseded | [clm_629467E441EC](/claim/clm_629467E441EC.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_research_and_development | 1,354,000,000 United States dollar | superseded | [clm_C779B75DFED6](/claim/clm_C779B75DFED6.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_revenue | 22,397,000,000 United States dollar | superseded | [clm_7F27B9D049DC](/claim/clm_7F27B9D049DC.md)
- 2014-09-30 to 2015-02-10 | money | shares_outstanding | 989,660,472 shares | superseded | [clm_3C9C90D14D88](/claim/clm_3C9C90D14D88.md)
- 2014-09-30 to 2014-12-31 | money | total_assets | 118,911,000,000 United States dollar | superseded | [clm_A796041D29FC](/claim/clm_A796041D29FC.md)
- 2014-09-30 to 2014-12-31 | money | total_equity | 14,255,000,000 United States dollar | superseded | [clm_F6D41775F588](/claim/clm_F6D41775F588.md)
- 2014-12-31 to 2015-03-31 | money | cash_and_equivalents | 8,476,000,000 United States dollar | superseded | [clm_C20C38C99A05](/claim/clm_C20C38C99A05.md)
- 2014-12-31 to 2015-12-31 | money | research_and_development | 5,437,000,000 United States dollar | superseded | [clm_82CA18A76192](/claim/clm_82CA18A76192.md)
- 2014-12-31 to 2015-12-31 | money | revenue | 92,793,000,000 United States dollar | superseded | [clm_3A8C04F54BDB](/claim/clm_3A8C04F54BDB.md)
- 2014-12-31 to 2015-03-31 | money | total_assets | 117,532,000,000 United States dollar | superseded | [clm_2AA38AC3A23F](/claim/clm_2AA38AC3A23F.md)
- 2014-12-31 to 2015-03-31 | money | total_equity | 11,868,000,000 United States dollar | superseded | [clm_494A936CB8F3](/claim/clm_494A936CB8F3.md)

## 2015

- 2015-02-10 to 2015-03-31 | money | shares_outstanding | 988,424,172 shares | superseded | [clm_E3ACB14548DD](/claim/clm_E3ACB14548DD.md)
- 2015-03-31 to 2015-06-30 | money | cash_and_equivalents | 8,796,000,000 United States dollar | superseded | [clm_D881C9F6C711](/claim/clm_D881C9F6C711.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_research_and_development | 1,298,000,000 United States dollar | superseded | [clm_24D174D841A4](/claim/clm_24D174D841A4.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_revenue | 19,590,000,000 United States dollar | superseded | [clm_317FD45DC3E8](/claim/clm_317FD45DC3E8.md)
- 2015-03-31 to 2015-06-30 | money | shares_outstanding | 984,734,067 shares | superseded | [clm_193CF38B76E8](/claim/clm_193CF38B76E8.md)
- 2015-03-31 to 2015-06-30 | money | total_assets | 112,037,000,000 United States dollar | superseded | [clm_BD7A21EC645F](/claim/clm_BD7A21EC645F.md)
- 2015-03-31 to 2015-06-30 | money | total_equity | 12,141,000,000 United States dollar | superseded | [clm_FB6A9504E496](/claim/clm_FB6A9504E496.md)
- 2015-06-30 to 2015-09-30 | money | cash_and_equivalents | 8,393,000,000 United States dollar | superseded | [clm_E4CF429E8294](/claim/clm_E4CF429E8294.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_research_and_development | 1,300,000,000 United States dollar | superseded | [clm_96A09652E03F](/claim/clm_96A09652E03F.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_revenue | 20,813,000,000 United States dollar | superseded | [clm_67749CB18A87](/claim/clm_67749CB18A87.md)
- 2015-06-30 to 2015-09-30 | money | shares_outstanding | 979,529,828 shares | superseded | [clm_36760A7B5712](/claim/clm_36760A7B5712.md)
- 2015-06-30 to 2015-09-30 | money | total_assets | 112,729,000,000 United States dollar | superseded | [clm_C9428F22087D](/claim/clm_C9428F22087D.md)
- 2015-06-30 to 2015-09-30 | money | total_equity | 13,684,000,000 United States dollar | superseded | [clm_2C1D78042EB5](/claim/clm_2C1D78042EB5.md)
- 2015-09-30 to 2015-12-31 | money | cash_and_equivalents | 9,480,000,000 United States dollar | superseded | [clm_63D5FC7BE19B](/claim/clm_63D5FC7BE19B.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_research_and_development | 1,287,000,000 United States dollar | superseded | [clm_B4BE472F6598](/claim/clm_B4BE472F6598.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_revenue | 19,280,000,000 United States dollar | superseded | [clm_0D6397FBDBD1](/claim/clm_0D6397FBDBD1.md)
- 2015-09-30 to 2016-02-10 | money | shares_outstanding | 970,110,126 shares | superseded | [clm_287E05BAD9BD](/claim/clm_287E05BAD9BD.md)
- 2015-09-30 to 2015-12-31 | money | total_assets | 108,649,000,000 United States dollar | superseded | [clm_E8785C7D925E](/claim/clm_E8785C7D925E.md)
- 2015-09-30 to 2015-12-31 | money | total_equity | 13,294,000,000 United States dollar | superseded | [clm_C5290D948643](/claim/clm_C5290D948643.md)
- 2015-12-31 to 2016-03-31 | money | cash_and_equivalents | 7,686,000,000 United States dollar | superseded | [clm_E3ADAC883D0F](/claim/clm_E3ADAC883D0F.md)
- 2015-12-31 to 2016-12-31 | money | net_income | 13,190,000,000 United States dollar | superseded | [clm_DE66E53C1B28](/claim/clm_DE66E53C1B28.md)
- 2015-12-31 to 2016-12-31 | money | research_and_development | 5,247,000,000 United States dollar | superseded | [clm_A01BBBF2AB5C](/claim/clm_A01BBBF2AB5C.md)
- 2015-12-31 to 2016-12-31 | money | revenue | 81,741,000,000 United States dollar | superseded | [clm_69007BC645E8](/claim/clm_69007BC645E8.md)
- 2015-12-31 to 2016-03-31 | money | total_assets | 110,495,000,000 United States dollar | superseded | [clm_7FB0BA99D11B](/claim/clm_7FB0BA99D11B.md)
- 2015-12-31 to 2016-03-31 | money | total_equity | 14,262,000,000 United States dollar | superseded | [clm_87D4F6ECCAC1](/claim/clm_87D4F6ECCAC1.md)

## 2016

- 2016-02-10 to 2016-03-31 | money | shares_outstanding | 988,424,172 shares | superseded | [clm_EF52B9FAE445](/claim/clm_EF52B9FAE445.md)
- 2016-03-31 to 2016-06-30 | money | cash_and_equivalents | 14,354,000,000 United States dollar | superseded | [clm_C93546E2391F](/claim/clm_C93546E2391F.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_net_income | 2,014,000,000 United States dollar | superseded | [clm_B645C7D485F0](/claim/clm_B645C7D485F0.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_research_and_development | 1,458,000,000 United States dollar | superseded | [clm_E5A6072A821D](/claim/clm_E5A6072A821D.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_revenue | 18,684,000,000 United States dollar | superseded | [clm_2D48BCA1BA00](/claim/clm_2D48BCA1BA00.md)
- 2016-03-31 to 2016-06-30 | money | shares_outstanding | 959,961,852 shares | superseded | [clm_1516CEED5BD9](/claim/clm_1516CEED5BD9.md)
- 2016-03-31 to 2016-06-30 | money | total_assets | 118,856,000,000 United States dollar | superseded | [clm_2CF8CA451D7D](/claim/clm_2CF8CA451D7D.md)
- 2016-03-31 to 2016-06-30 | money | total_equity | 14,925,000,000 United States dollar | superseded | [clm_FE9178DB4A80](/claim/clm_FE9178DB4A80.md)
- 2016-06-30 to 2016-09-30 | money | cash_and_equivalents | 10,017,000,000 United States dollar | superseded | [clm_FBF98B3288CB](/claim/clm_FBF98B3288CB.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_net_income | 2,504,000,000 United States dollar | superseded | [clm_A21A72464D57](/claim/clm_A21A72464D57.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_research_and_development | 1,465,000,000 United States dollar | superseded | [clm_4DA2F5DD8988](/claim/clm_4DA2F5DD8988.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_revenue | 20,238,000,000 United States dollar | superseded | [clm_C6BB522FA024](/claim/clm_C6BB522FA024.md)
- 2016-06-30 to 2016-09-30 | money | shares_outstanding | 955,844,217 shares | superseded | [clm_31CFE02700BB](/claim/clm_31CFE02700BB.md)
- 2016-06-30 to 2016-09-30 | money | total_assets | 118,056,000,000 United States dollar | superseded | [clm_CC5B7ECDD822](/claim/clm_CC5B7ECDD822.md)
- 2016-06-30 to 2016-09-30 | money | total_equity | 15,733,000,000 United States dollar | superseded | [clm_C7BC4DF8238F](/claim/clm_C7BC4DF8238F.md)
- 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 9,039,000,000 United States dollar | superseded | [clm_AE9EADD8262D](/claim/clm_AE9EADD8262D.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_net_income | 2,853,000,000 United States dollar | superseded | [clm_3733D5DBDF38](/claim/clm_3733D5DBDF38.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_research_and_development | 1,397,000,000 United States dollar | superseded | [clm_37D46E069555](/claim/clm_37D46E069555.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_revenue | 19,226,000,000 United States dollar | superseded | [clm_A306480D8837](/claim/clm_A306480D8837.md)
- 2016-09-30 to 2017-02-10 | money | shares_outstanding | 950,854,551 shares | superseded | [clm_6534A671A6AB](/claim/clm_6534A671A6AB.md)
- 2016-09-30 to 2016-12-31 | money | total_assets | 115,606,000,000 United States dollar | superseded | [clm_EAE04D694E66](/claim/clm_EAE04D694E66.md)
- 2016-09-30 to 2016-12-31 | money | total_equity | 17,010,000,000 United States dollar | superseded | [clm_A98DD0C74F24](/claim/clm_A98DD0C74F24.md)
- 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 7,826,000,000 United States dollar | superseded | [clm_AFEA358A8528](/claim/clm_AFEA358A8528.md)
- 2016-12-31 to 2017-12-31 | money | net_income | 11,872,000,000 United States dollar | superseded | [clm_9130DB6B47C0](/claim/clm_9130DB6B47C0.md)
- 2016-12-31 to 2017-12-31 | money | research_and_development | 5,751,000,000 United States dollar | superseded | [clm_BD1F3DFA8098](/claim/clm_BD1F3DFA8098.md)
- 2016-12-31 to 2017-12-31 | money | revenue | 79,919,000,000 United States dollar | superseded | [clm_9437F7207AC4](/claim/clm_9437F7207AC4.md)
- 2016-12-31 to 2017-03-31 | money | total_assets | 117,470,000,000 United States dollar | superseded | [clm_8F846124E9DB](/claim/clm_8F846124E9DB.md)
- 2016-12-31 to 2017-03-31 | money | total_equity | 18,246,000,000 United States dollar | superseded | [clm_9D1C9714905E](/claim/clm_9D1C9714905E.md)

## 2017

- 2017-02-10 to 2017-03-31 | money | shares_outstanding | 943,212,551 shares | superseded | [clm_DE652F45A5D8](/claim/clm_DE652F45A5D8.md)
- 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 10,096,000,000 United States dollar | superseded | [clm_75C30235F5C2](/claim/clm_75C30235F5C2.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_net_income | 1,750,000,000 United States dollar | superseded | [clm_EA2E8D3981AA](/claim/clm_EA2E8D3981AA.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_research_and_development | 1,533,000,000 United States dollar | superseded | [clm_288B9096B908](/claim/clm_288B9096B908.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 18,155,000,000 United States dollar | superseded | [clm_FFAD171EEEA2](/claim/clm_FFAD171EEEA2.md)
- 2017-03-31 to 2017-06-30 | money | shares_outstanding | 939,496,884 shares | superseded | [clm_B5D7030BE015](/claim/clm_B5D7030BE015.md)
- 2017-03-31 to 2017-06-30 | money | total_assets | 117,495,000,000 United States dollar | superseded | [clm_59E7123EB729](/claim/clm_59E7123EB729.md)
- 2017-03-31 to 2017-06-30 | money | total_equity | 18,327,000,000 United States dollar | superseded | [clm_084C2DD6482D](/claim/clm_084C2DD6482D.md)
- 2017-06-30 to 2017-09-30 | money | cash_and_equivalents | 11,696,000,000 United States dollar | superseded | [clm_00EAD176446E](/claim/clm_00EAD176446E.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_net_income | 2,331,000,000 United States dollar | superseded | [clm_12ADE9F5DBAC](/claim/clm_12ADE9F5DBAC.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_research_and_development | 1,484,000,000 United States dollar | superseded | [clm_089E5AC2E54A](/claim/clm_089E5AC2E54A.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_revenue | 19,289,000,000 United States dollar | superseded | [clm_4165BCBAD819](/claim/clm_4165BCBAD819.md)
- 2017-06-30 to 2017-09-30 | money | shares_outstanding | 931,940,297 shares | superseded | [clm_45C294AC5E09](/claim/clm_45C294AC5E09.md)
- 2017-06-30 to 2017-09-30 | money | total_assets | 120,495,000,000 United States dollar | superseded | [clm_9EAF2A9EF52D](/claim/clm_9EAF2A9EF52D.md)
- 2017-06-30 to 2017-09-30 | money | total_equity | 18,419,000,000 United States dollar | superseded | [clm_06806FC62DDC](/claim/clm_06806FC62DDC.md)
- 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 10,915,000,000 United States dollar | superseded | [clm_9892ABF47D67](/claim/clm_9892ABF47D67.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_net_income | 2,726,000,000 United States dollar | superseded | [clm_B128B56B2716](/claim/clm_B128B56B2716.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_research_and_development | 1,342,000,000 United States dollar | superseded | [clm_82A155B1B65D](/claim/clm_82A155B1B65D.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_revenue | 19,153,000,000 United States dollar | superseded | [clm_E5F449E8F1D4](/claim/clm_E5F449E8F1D4.md)
- 2017-09-30 to 2018-02-09 | money | shares_outstanding | 925,791,378 shares | superseded | [clm_7D1B93443E1C](/claim/clm_7D1B93443E1C.md)
- 2017-09-30 to 2017-12-31 | money | total_assets | 121,636,000,000 United States dollar | superseded | [clm_F273F143A88A](/claim/clm_F273F143A88A.md)
- 2017-09-30 to 2017-12-31 | money | total_equity | 19,627,000,000 United States dollar | superseded | [clm_31509A065F04](/claim/clm_31509A065F04.md)
- 2017-12-31 to 2018-03-31 | money | cash_and_equivalents | 11,972,000,000 United States dollar | superseded | [clm_2BDC8830F8DD](/claim/clm_2BDC8830F8DD.md)
- 2017-12-31 to 2018-12-31 | money | net_income | 5,753,000,000 United States dollar | superseded | [clm_6926A4A9EF7C](/claim/clm_6926A4A9EF7C.md)
- 2017-12-31 to 2018-12-31 | money | research_and_development | 5,787,000,000 United States dollar | superseded | [clm_943EAC2F36A1](/claim/clm_943EAC2F36A1.md)
- 2017-12-31 to 2018-12-31 | money | revenue | 79,139,000,000 United States dollar | superseded | [clm_8640E73FAD15](/claim/clm_8640E73FAD15.md)
- 2017-12-31 to 2018-03-31 | money | total_assets | 125,356,000,000 United States dollar | superseded | [clm_B0254C093F22](/claim/clm_B0254C093F22.md)
- 2017-12-31 to 2018-03-31 | money | total_equity | 17,594,000,000 United States dollar | superseded | [clm_CAA3686F5396](/claim/clm_CAA3686F5396.md)

## 2018

- 2018-01-11 | people | cfo | James Kavanaugh | valid | [clm_7C5C920799C4](/claim/clm_7C5C920799C4.md)
- 2018-02-09 to 2018-03-31 | money | shares_outstanding | 921,167,894 shares | superseded | [clm_8F6C558BF63A](/claim/clm_8F6C558BF63A.md)
- 2018-03-31 to 2018-06-30 | money | cash_and_equivalents | 11,949,000,000 United States dollar | superseded | [clm_B8EF4990F335](/claim/clm_B8EF4990F335.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_net_income | 1,679,000,000 United States dollar | superseded | [clm_9F2ACBE06607](/claim/clm_9F2ACBE06607.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 1,405,000,000 United States dollar | superseded | [clm_A49D09BF8375](/claim/clm_A49D09BF8375.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 19,072,000,000 United States dollar | superseded | [clm_F0F494766575](/claim/clm_F0F494766575.md)
- 2018-03-31 to 2018-06-30 | money | shares_outstanding | 917,968,306 shares | superseded | [clm_DBB640CB432F](/claim/clm_DBB640CB432F.md)
- 2018-03-31 to 2018-06-30 | money | total_assets | 125,285,000,000 United States dollar | superseded | [clm_8DA0BBE6D65D](/claim/clm_8DA0BBE6D65D.md)
- 2018-03-31 to 2018-06-30 | money | total_equity | 18,166,000,000 United States dollar | superseded | [clm_6D653057C5C4](/claim/clm_6D653057C5C4.md)
- 2018-06-02 | products | released | IBM Plex Sans Hebrew | unverified | [clm_0BE7AC0BF00A](/claim/clm_0BE7AC0BF00A.md)
- 2018-06-30 to 2018-09-30 | money | cash_and_equivalents | 10,741,000,000 United States dollar | superseded | [clm_F349E34DFB12](/claim/clm_F349E34DFB12.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_net_income | 2,404,000,000 United States dollar | superseded | [clm_BCF174B38872](/claim/clm_BCF174B38872.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 1,364,000,000 United States dollar | superseded | [clm_0081D183BEEB](/claim/clm_0081D183BEEB.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 20,003,000,000 United States dollar | superseded | [clm_8D74EDF840CD](/claim/clm_8D74EDF840CD.md)
- 2018-06-30 to 2018-09-30 | money | shares_outstanding | 912,768,189 shares | superseded | [clm_E37189AEC8D8](/claim/clm_E37189AEC8D8.md)
- 2018-06-30 to 2018-09-30 | money | total_assets | 121,622,000,000 United States dollar | superseded | [clm_AD02DEB780F3](/claim/clm_AD02DEB780F3.md)
- 2018-06-30 to 2018-09-30 | money | total_equity | 18,520,000,000 United States dollar | superseded | [clm_29FCEF28A11B](/claim/clm_29FCEF28A11B.md)
- 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 11,563,000,000 United States dollar | superseded | [clm_3D605F3ED5DE](/claim/clm_3D605F3ED5DE.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_net_income | 2,694,000,000 United States dollar | superseded | [clm_E7753BC140E2](/claim/clm_E7753BC140E2.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 1,252,000,000 United States dollar | superseded | [clm_EDFBDC80695E](/claim/clm_EDFBDC80695E.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 18,756,000,000 United States dollar | superseded | [clm_F0C63372DB9C](/claim/clm_F0C63372DB9C.md)
- 2018-09-30 to 2019-02-08 | money | shares_outstanding | 908,793,777 shares | superseded | [clm_2E21BAC259FF](/claim/clm_2E21BAC259FF.md)
- 2018-09-30 to 2018-12-31 | money | total_assets | 121,990,000,000 United States dollar | superseded | [clm_2F96127D7A1E](/claim/clm_2F96127D7A1E.md)
- 2018-09-30 to 2018-12-31 | money | total_equity | 19,784,000,000 United States dollar | superseded | [clm_A2E9B4E4CF54](/claim/clm_A2E9B4E4CF54.md)
- 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 11,379,000,000 United States dollar | superseded | [clm_9770E004AB53](/claim/clm_9770E004AB53.md)
- 2018-12-31 to 2019-12-31 | money | net_income | 8,728,000,000 United States dollar | superseded | [clm_F9B43B15778E](/claim/clm_F9B43B15778E.md)
- 2018-12-31 to 2019-12-31 | money | research_and_development | 5,379,000,000 United States dollar | superseded | [clm_32F0F3EA46F7](/claim/clm_32F0F3EA46F7.md)
- 2018-12-31 to 2019-12-31 | money | revenue | 79,591,000,000 United States dollar | superseded | [clm_6C421327858F](/claim/clm_6C421327858F.md)
- 2018-12-31 to 2019-03-31 | money | total_assets | 123,382,000,000 United States dollar | superseded | [clm_80C6207BB1B9](/claim/clm_80C6207BB1B9.md)
- 2018-12-31 to 2019-03-31 | money | total_equity | 16,796,000,000 United States dollar | superseded | [clm_D6513CBA442A](/claim/clm_D6513CBA442A.md)

## 2019

- 2019-01-01 | people | board_member | Michelle J. Howard | valid | [clm_671344BDD53F](/claim/clm_671344BDD53F.md)
- 2019-02-08 to 2019-03-31 | money | shares_outstanding | 889,866,256 shares | superseded | [clm_6CABE9C51DC9](/claim/clm_6CABE9C51DC9.md)
- 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 17,134,000,000 United States dollar | superseded | [clm_25B949A29F2A](/claim/clm_25B949A29F2A.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_net_income | 1,591,000,000 United States dollar | superseded | [clm_135B12AC6CEC](/claim/clm_135B12AC6CEC.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 1,433,000,000 United States dollar | superseded | [clm_93DB2FAF841E](/claim/clm_93DB2FAF841E.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 18,182,000,000 United States dollar | superseded | [clm_153159EF7F16](/claim/clm_153159EF7F16.md)
- 2019-03-31 to 2019-06-30 | money | shares_outstanding | 886,642,873 shares | superseded | [clm_7DB92C174E34](/claim/clm_7DB92C174E34.md)
- 2019-03-31 to 2019-06-30 | money | total_assets | 130,926,000,000 United States dollar | superseded | [clm_B34E15B126D3](/claim/clm_B34E15B126D3.md)
- 2019-03-31 to 2019-06-30 | money | total_equity | 16,481,000,000 United States dollar | superseded | [clm_E1A47E43D8CA](/claim/clm_E1A47E43D8CA.md)
- 2019-06-30 to 2019-09-30 | money | cash_and_equivalents | 45,399,000,000 United States dollar | superseded | [clm_99A94EB71951](/claim/clm_99A94EB71951.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_net_income | 2,498,000,000 United States dollar | superseded | [clm_A42D42B97763](/claim/clm_A42D42B97763.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 1,407,000,000 United States dollar | superseded | [clm_FA43DD167568](/claim/clm_FA43DD167568.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 19,161,000,000 United States dollar | superseded | [clm_022F04B3E65A](/claim/clm_022F04B3E65A.md)
- 2019-06-30 to 2019-09-30 | money | shares_outstanding | 885,875,161 shares | superseded | [clm_CB0BE153A076](/claim/clm_CB0BE153A076.md)
- 2019-06-30 to 2019-09-30 | money | total_assets | 154,652,000,000 United States dollar | superseded | [clm_164CF8206BB5](/claim/clm_164CF8206BB5.md)
- 2019-06-30 to 2019-09-30 | money | total_equity | 17,645,000,000 United States dollar | superseded | [clm_41BD8F7F9009](/claim/clm_41BD8F7F9009.md)
- 2019-07-09 | other | subsidiary | Red Hat | valid | [clm_7DBD102C1630](/claim/clm_7DBD102C1630.md)
- 2019-09-30 to 2019-12-31 | money | cash_and_equivalents | 10,087,000,000 United States dollar | superseded | [clm_6F8967CDC7CC](/claim/clm_6F8967CDC7CC.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_net_income | 1,672,000,000 United States dollar | superseded | [clm_8CA8D9C7E024](/claim/clm_8CA8D9C7E024.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 1,553,000,000 United States dollar | superseded | [clm_E27D4F30DC64](/claim/clm_E27D4F30DC64.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 18,028,000,000 United States dollar | superseded | [clm_38D37EED4D0A](/claim/clm_38D37EED4D0A.md)
- 2019-09-30 to 2020-02-10 | money | shares_outstanding | 885,637,454 shares | superseded | [clm_5BBA193EEF8E](/claim/clm_5BBA193EEF8E.md)
- 2019-09-30 to 2019-12-31 | money | total_assets | 149,620,000,000 United States dollar | superseded | [clm_14D4AC1A0F12](/claim/clm_14D4AC1A0F12.md)
- 2019-09-30 to 2019-12-31 | money | total_equity | 17,956,000,000 United States dollar | superseded | [clm_D29EFA647445](/claim/clm_D29EFA647445.md)
- 2019-12-31 to 2020-03-31 | money | cash_and_equivalents | 8,172,000,000 United States dollar | superseded | [clm_7A9C1B037109](/claim/clm_7A9C1B037109.md)
- 2019-12-31 to 2025-12-31 | money | employees | 352,600 | superseded | [clm_FF49F97E979D](/claim/clm_FF49F97E979D.md)
- 2019-12-31 to 2020-12-31 | money | net_income | 9,431,000,000 United States dollar | superseded | [clm_431806BDF776](/claim/clm_431806BDF776.md)
- 2019-12-31 to 2020-12-31 | money | research_and_development | 5,989,000,000 United States dollar | superseded | [clm_2B0AED7D1B1F](/claim/clm_2B0AED7D1B1F.md)
- 2019-12-31 to 2020-12-31 | money | revenue | 77,147,000,000 United States dollar | superseded | [clm_D53C1426B3B5](/claim/clm_D53C1426B3B5.md)
- 2019-12-31 to 2020-03-31 | money | total_assets | 152,186,000,000 United States dollar | superseded | [clm_82DEDEE9ECDD](/claim/clm_82DEDEE9ECDD.md)
- 2019-12-31 to 2020-03-31 | money | total_equity | 20,841,000,000 United States dollar | superseded | [clm_FECA32B0FE24](/claim/clm_FECA32B0FE24.md)

## 2020

- 2020-02-10 to 2020-03-31 | money | shares_outstanding | 888,408,023 shares | superseded | [clm_15D546257289](/claim/clm_15D546257289.md)
- 2020-03-31 to 2020-06-30 | money | cash_and_equivalents | 11,218,000,000 United States dollar | superseded | [clm_7F74A963C38E](/claim/clm_7F74A963C38E.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_net_income | 1,175,000,000 United States dollar | superseded | [clm_5D22700FD5CD](/claim/clm_5D22700FD5CD.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_research_and_development | 1,625,000,000 United States dollar | superseded | [clm_E411A8597089](/claim/clm_E411A8597089.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 17,571,000,000 United States dollar | superseded | [clm_785730DC23E6](/claim/clm_785730DC23E6.md)
- 2020-03-31 to 2020-06-30 | money | shares_outstanding | 887,891,957 shares | superseded | [clm_2B4EB5A16E74](/claim/clm_2B4EB5A16E74.md)
- 2020-03-31 to 2020-06-30 | money | total_assets | 153,403,000,000 United States dollar | superseded | [clm_04B999D822C3](/claim/clm_04B999D822C3.md)
- 2020-03-31 to 2020-06-30 | money | total_equity | 19,999,000,000 United States dollar | superseded | [clm_20AFF97C3D27](/claim/clm_20AFF97C3D27.md)
- 2020-04-01 | people | ceo | [Arvind Krishna](/record/arvind-krishna.md) | valid | [clm_4D0ED56410A0](/claim/clm_4D0ED56410A0.md)
- 2020-06-30 to 2020-09-30 | money | cash_and_equivalents | 12,041,000,000 United States dollar | superseded | [clm_54F89CEE5C46](/claim/clm_54F89CEE5C46.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_net_income | 1,361,000,000 United States dollar | superseded | [clm_34B341523F30](/claim/clm_34B341523F30.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_research_and_development | 1,582,000,000 United States dollar | superseded | [clm_177F1C9624A0](/claim/clm_177F1C9624A0.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 18,123,000,000 United States dollar | superseded | [clm_38CD7E6B1253](/claim/clm_38CD7E6B1253.md)
- 2020-06-30 to 2020-09-30 | money | shares_outstanding | 890,578,748 shares | superseded | [clm_A49EC55068AD](/claim/clm_A49EC55068AD.md)
- 2020-06-30 to 2020-09-30 | money | total_assets | 154,200,000,000 United States dollar | superseded | [clm_6CFDAF4601A8](/claim/clm_6CFDAF4601A8.md)
- 2020-06-30 to 2020-09-30 | money | total_equity | 20,551,000,000 United States dollar | superseded | [clm_FA1A11D3C10D](/claim/clm_FA1A11D3C10D.md)
- 2020-09-30 to 2020-12-31 | money | cash_and_equivalents | 14,393,000,000 United States dollar | superseded | [clm_53AEA7085689](/claim/clm_53AEA7085689.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_net_income | 1,698,000,000 United States dollar | superseded | [clm_03E924EB6F6F](/claim/clm_03E924EB6F6F.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_research_and_development | 1,515,000,000 United States dollar | superseded | [clm_A81D88090B5A](/claim/clm_A81D88090B5A.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 17,560,000,000 United States dollar | superseded | [clm_09BEDDAA206E](/claim/clm_09BEDDAA206E.md)
- 2020-09-30 to 2021-02-10 | money | shares_outstanding | 891,057,116 shares | superseded | [clm_A80590716C42](/claim/clm_A80590716C42.md)
- 2020-09-30 to 2020-12-31 | money | total_assets | 154,128,000,000 United States dollar | superseded | [clm_201301E98946](/claim/clm_201301E98946.md)
- 2020-09-30 to 2020-12-31 | money | total_equity | 21,208,000,000 United States dollar | superseded | [clm_9C00579BA0A8](/claim/clm_9C00579BA0A8.md)
- 2020-12-31 to 2021-03-31 | money | cash_and_equivalents | 13,212,000,000 United States dollar | superseded | [clm_1E18FAE70C46](/claim/clm_1E18FAE70C46.md)
- 2020-12-31 to 2021-12-31 | money | net_income | 5,590,000,000 United States dollar | superseded | [clm_DD8A43D9775A](/claim/clm_DD8A43D9775A.md)
- 2020-12-31 to 2021-12-31 | money | research_and_development | 6,333,000,000 United States dollar | superseded | [clm_BB5A56217A3B](/claim/clm_BB5A56217A3B.md)
- 2020-12-31 to 2021-12-31 | money | revenue | 73,620,000,000 United States dollar | superseded | [clm_9B7A79435626](/claim/clm_9B7A79435626.md)
- 2020-12-31 to 2021-03-31 | money | total_assets | 155,971,000,000 United States dollar | superseded | [clm_C4661C3CBA7E](/claim/clm_C4661C3CBA7E.md)
- 2020-12-31 to 2021-03-31 | money | total_equity | 20,597,000,000 United States dollar | superseded | [clm_AFAE7A67B8B2](/claim/clm_AFAE7A67B8B2.md)

## 2021

- 2021-01-01 | people | chair | [Arvind Krishna](/record/arvind-krishna.md) | unverified | [clm_3ED8DBE39F61](/claim/clm_3ED8DBE39F61.md)
- 2021-02-10 to 2021-03-31 | money | shares_outstanding | 893,594,090 shares | superseded | [clm_FC9F2B422A17](/claim/clm_FC9F2B422A17.md)
- 2021-03-31 to 2021-06-30 | money | cash_and_equivalents | 10,531,000,000 United States dollar | superseded | [clm_1D78BAE58717](/claim/clm_1D78BAE58717.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_net_income | 955,000,000 United States dollar | superseded | [clm_D5C54D6F90AF](/claim/clm_D5C54D6F90AF.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_research_and_development | 1,630,000,000 United States dollar | superseded | [clm_A86807883A16](/claim/clm_A86807883A16.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 17,730,000,000 United States dollar | superseded | [clm_A9173E1781A1](/claim/clm_A9173E1781A1.md)
- 2021-03-31 to 2021-06-30 | money | shares_outstanding | 893,522,828 shares | superseded | [clm_0C0999F74269](/claim/clm_0C0999F74269.md)
- 2021-03-31 to 2021-06-30 | money | total_assets | 148,629,000,000 United States dollar | superseded | [clm_C983966C89FD](/claim/clm_C983966C89FD.md)
- 2021-03-31 to 2021-06-30 | money | total_equity | 21,389,000,000 United States dollar | superseded | [clm_96756EC325EF](/claim/clm_96756EC325EF.md)
- 2021-06-30 to 2021-09-30 | money | cash_and_equivalents | 7,350,000,000 United States dollar | superseded | [clm_BBF6FBF9A23B](/claim/clm_BBF6FBF9A23B.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_net_income | 1,325,000,000 United States dollar | superseded | [clm_0D84E5F54D3F](/claim/clm_0D84E5F54D3F.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_research_and_development | 1,657,000,000 United States dollar | superseded | [clm_22EE86C2AA4B](/claim/clm_22EE86C2AA4B.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 18,745,000,000 United States dollar | superseded | [clm_0B4A118E0992](/claim/clm_0B4A118E0992.md)
- 2021-06-30 to 2021-09-30 | money | shares_outstanding | 896,320,073 shares | superseded | [clm_C9786A29C507](/claim/clm_C9786A29C507.md)
- 2021-06-30 to 2021-09-30 | money | total_assets | 146,814,000,000 United States dollar | superseded | [clm_5C54F59B4A11](/claim/clm_5C54F59B4A11.md)
- 2021-06-30 to 2021-09-30 | money | total_equity | 21,942,000,000 United States dollar | superseded | [clm_37AAED865ADB](/claim/clm_37AAED865ADB.md)
- 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 7,455,000,000 United States dollar | superseded | [clm_1880DFCEA8D7](/claim/clm_1880DFCEA8D7.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_net_income | 1,130,000,000 United States dollar | superseded | [clm_22EC96099FA3](/claim/clm_22EC96099FA3.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_research_and_development | 1,621,000,000 United States dollar | superseded | [clm_CC8EBDC77559](/claim/clm_CC8EBDC77559.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 17,618,000,000 United States dollar | superseded | [clm_24F93631B733](/claim/clm_24F93631B733.md)
- 2021-09-30 to 2022-02-11 | money | shares_outstanding | 896,800,350 shares | superseded | [clm_45AB886B0245](/claim/clm_45AB886B0245.md)
- 2021-09-30 to 2021-12-31 | money | total_assets | 144,214,000,000 United States dollar | superseded | [clm_8455923FCFDC](/claim/clm_8455923FCFDC.md)
- 2021-09-30 to 2021-12-31 | money | total_equity | 22,228,000,000 United States dollar | superseded | [clm_0E2D38605DB8](/claim/clm_0E2D38605DB8.md)
- 2021-10-25 | people | board_member | Al Zollar | valid | [clm_97EA1BF4F9CE](/claim/clm_97EA1BF4F9CE.md)
- 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 6,650,000,000 United States dollar | superseded | [clm_16F475D16031](/claim/clm_16F475D16031.md)
- 2021-12-31 to 2022-12-31 | money | net_income | 5,743,000,000 United States dollar | superseded | [clm_7A2EA0ACE0D3](/claim/clm_7A2EA0ACE0D3.md)
- 2021-12-31 to 2022-12-31 | money | research_and_development | 6,488,000,000 United States dollar | superseded | [clm_A8C41CAAE572](/claim/clm_A8C41CAAE572.md)
- 2021-12-31 to 2022-12-31 | money | revenue | 57,350,000,000 United States dollar | superseded | [clm_A3944665E4B3](/claim/clm_A3944665E4B3.md)
- 2021-12-31 to 2022-03-31 | money | total_assets | 132,001,000,000 United States dollar | superseded | [clm_3018DF0BA269](/claim/clm_3018DF0BA269.md)
- 2021-12-31 to 2022-03-31 | money | total_equity | 18,901,000,000 United States dollar | superseded | [clm_5F81260BAEBD](/claim/clm_5F81260BAEBD.md)

## 2022

- 2022-02-11 to 2022-03-31 | money | shares_outstanding | 899,309,986 shares | superseded | [clm_DE53A7A1C065](/claim/clm_DE53A7A1C065.md)
- 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 9,934,000,000 United States dollar | superseded | [clm_0D9344ABAC38](/claim/clm_0D9344ABAC38.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_net_income | 733,000,000 United States dollar | superseded | [clm_594C93BB5151](/claim/clm_594C93BB5151.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_research_and_development | 1,679,000,000 United States dollar | superseded | [clm_0849AD0DC063](/claim/clm_0849AD0DC063.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 14,197,000,000 United States dollar | superseded | [clm_9B465746CACA](/claim/clm_9B465746CACA.md)
- 2022-03-31 to 2022-06-30 | money | shares_outstanding | 899,435,325 shares | superseded | [clm_A9644F5E771E](/claim/clm_A9644F5E771E.md)
- 2022-03-31 to 2022-06-30 | money | total_assets | 133,275,000,000 United States dollar | superseded | [clm_596C90C033E0](/claim/clm_596C90C033E0.md)
- 2022-03-31 to 2022-06-30 | money | total_equity | 19,050,000,000 United States dollar | superseded | [clm_5B1B7F477508](/claim/clm_5B1B7F477508.md)
- 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 7,034,000,000 United States dollar | superseded | [clm_F4397492FFED](/claim/clm_F4397492FFED.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_net_income | 1,392,000,000 United States dollar | superseded | [clm_A58B75108DDE](/claim/clm_A58B75108DDE.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_research_and_development | 1,673,000,000 United States dollar | superseded | [clm_78D8514AE8D8](/claim/clm_78D8514AE8D8.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 15,535,000,000 United States dollar | superseded | [clm_7D73C96BCA74](/claim/clm_7D73C96BCA74.md)
- 2022-06-30 to 2022-09-30 | money | shares_outstanding | 903,180,353 shares | superseded | [clm_B3D5199FAA87](/claim/clm_B3D5199FAA87.md)
- 2022-06-30 to 2022-09-30 | money | total_assets | 127,503,000,000 United States dollar | superseded | [clm_1FDD80212099](/claim/clm_1FDD80212099.md)
- 2022-06-30 to 2022-09-30 | money | total_equity | 19,409,000,000 United States dollar | superseded | [clm_09934E2701D0](/claim/clm_09934E2701D0.md)
- 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 7,816,000,000 United States dollar | superseded | [clm_14AA7B5C7B7F](/claim/clm_14AA7B5C7B7F.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_net_income | -3,196,000,000 United States dollar | superseded | [clm_FA4F1896AE77](/claim/clm_FA4F1896AE77.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_research_and_development | 1,611,000,000 United States dollar | superseded | [clm_04D9A1CF8C1C](/claim/clm_04D9A1CF8C1C.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 14,107,000,000 United States dollar | superseded | [clm_5A4CAC21AB38](/claim/clm_5A4CAC21AB38.md)
- 2022-09-30 to 2023-02-10 | money | shares_outstanding | 904,126,363 shares | superseded | [clm_F1E1908A4A47](/claim/clm_F1E1908A4A47.md)
- 2022-09-30 to 2022-12-31 | money | total_assets | 125,850,000,000 United States dollar | superseded | [clm_FC69ECBC11A1](/claim/clm_FC69ECBC11A1.md)
- 2022-09-30 to 2022-12-31 | money | total_equity | 20,076,000,000 United States dollar | superseded | [clm_BC06504F8C6F](/claim/clm_BC06504F8C6F.md)
- 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 7,886,000,000 United States dollar | superseded | [clm_30B1DFB34063](/claim/clm_30B1DFB34063.md)
- 2022-12-31 to 2023-12-31 | money | net_income | 1,639,000,000 United States dollar | superseded | [clm_122364860236](/claim/clm_122364860236.md)
- 2022-12-31 to 2023-12-31 | money | research_and_development | 6,567,000,000 United States dollar | superseded | [clm_5F3EB8FD58F6](/claim/clm_5F3EB8FD58F6.md)
- 2022-12-31 to 2023-12-31 | money | revenue | 60,530,000,000 United States dollar | superseded | [clm_6A6CFFDE1B39](/claim/clm_6A6CFFDE1B39.md)
- 2022-12-31 to 2023-03-31 | money | total_assets | 127,243,000,000 United States dollar | superseded | [clm_D81FF1BF94FB](/claim/clm_D81FF1BF94FB.md)
- 2022-12-31 to 2023-03-31 | money | total_equity | 21,944,000,000 United States dollar | superseded | [clm_6A3D71F99156](/claim/clm_6A3D71F99156.md)

## 2023

- 2023-02-10 to 2023-03-31 | money | shares_outstanding | 907,105,611 shares | superseded | [clm_E6ABCB553B3D](/claim/clm_E6ABCB553B3D.md)
- 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 9,337,000,000 United States dollar | superseded | [clm_30C0AE074B27](/claim/clm_30C0AE074B27.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_net_income | 927,000,000 United States dollar | superseded | [clm_97460DFDC80D](/claim/clm_97460DFDC80D.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 1,655,000,000 United States dollar | superseded | [clm_87686C4AE54B](/claim/clm_87686C4AE54B.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 14,252,000,000 United States dollar | superseded | [clm_419664678C77](/claim/clm_419664678C77.md)
- 2023-03-31 to 2023-06-30 | money | shares_outstanding | 908,045,414 shares | superseded | [clm_92FC7133E883](/claim/clm_92FC7133E883.md)
- 2023-03-31 to 2023-06-30 | money | total_assets | 133,637,000,000 United States dollar | superseded | [clm_4AD267FD8B56](/claim/clm_4AD267FD8B56.md)
- 2023-03-31 to 2023-06-30 | money | total_equity | 21,604,000,000 United States dollar | superseded | [clm_DADB9220F71F](/claim/clm_DADB9220F71F.md)
- 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 9,394,000,000 United States dollar | superseded | [clm_490C6E663418](/claim/clm_490C6E663418.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_net_income | 1,583,000,000 United States dollar | superseded | [clm_0244A97D9F58](/claim/clm_0244A97D9F58.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_research_and_development | 1,687,000,000 United States dollar | superseded | [clm_2CD02C042D01](/claim/clm_2CD02C042D01.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 15,475,000,000 United States dollar | superseded | [clm_3852937E93D3](/claim/clm_3852937E93D3.md)
- 2023-06-30 to 2023-09-30 | money | shares_outstanding | 911,006,240 shares | superseded | [clm_6841F65A021C](/claim/clm_6841F65A021C.md)
- 2023-06-30 to 2023-09-30 | money | total_assets | 132,213,000,000 United States dollar | superseded | [clm_7AF5CE1C2026](/claim/clm_7AF5CE1C2026.md)
- 2023-06-30 to 2023-09-30 | money | total_equity | 22,201,000,000 United States dollar | superseded | [clm_94A377B97B72](/claim/clm_94A377B97B72.md)
- 2023-09-15 | other | hf_repo_created | ibm-granite/granite-timeseries-patchtsmixer | valid | [clm_966FE02752C6](/claim/clm_966FE02752C6.md)
- 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 7,257,000,000 United States dollar | superseded | [clm_6A6D4F7977F4](/claim/clm_6A6D4F7977F4.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_net_income | 1,704,000,000 United States dollar | superseded | [clm_FFF873A9164E](/claim/clm_FFF873A9164E.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_research_and_development | 1,685,000,000 United States dollar | superseded | [clm_1CDB88535875](/claim/clm_1CDB88535875.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 14,752,000,000 United States dollar | superseded | [clm_E4C26012AC20](/claim/clm_E4C26012AC20.md)
- 2023-09-30 to 2024-02-09 | money | shares_outstanding | 913,118,581 shares | superseded | [clm_C370C9747332](/claim/clm_C370C9747332.md)
- 2023-09-30 to 2023-12-31 | money | total_assets | 129,321,000,000 United States dollar | superseded | [clm_599845AD7AA1](/claim/clm_599845AD7AA1.md)
- 2023-09-30 to 2023-12-31 | money | total_equity | 23,081,000,000 United States dollar | superseded | [clm_EDC22D9AC0F5](/claim/clm_EDC22D9AC0F5.md)
- 2023-10-30 | people | board_member | [Michael Miebach](/record/michael-miebach.md) | valid | [clm_51AF9613396A](/claim/clm_51AF9613396A.md)
- 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 13,068,000,000 United States dollar | superseded | [clm_762407694B37](/claim/clm_762407694B37.md)
- 2023-12-31 to 2024-12-31 | money | net_income | 7,502,000,000 United States dollar | superseded | [clm_F0B6B8394D52](/claim/clm_F0B6B8394D52.md)
- 2023-12-31 to 2024-12-31 | money | research_and_development | 6,775,000,000 United States dollar | superseded | [clm_68482344E4AE](/claim/clm_68482344E4AE.md)
- 2023-12-31 to 2024-12-31 | money | revenue | 61,860,000,000 United States dollar | superseded | [clm_27D27FE3FC34](/claim/clm_27D27FE3FC34.md)
- 2023-12-31 to 2024-03-31 | money | total_assets | 135,241,000,000 United States dollar | superseded | [clm_2711ECE25F80](/claim/clm_2711ECE25F80.md)
- 2023-12-31 to 2024-03-31 | money | total_equity | 22,533,000,000 United States dollar | superseded | [clm_031DB4433885](/claim/clm_031DB4433885.md)

## 2024

- 2024-01-19 | other | hf_repo_created | ibm-granite/granite-timeseries-patchtst | valid | [clm_FDCD9F26CF9E](/claim/clm_FDCD9F26CF9E.md)
- 2024-02-09 to 2024-03-31 | money | shares_outstanding | 916,744,848 shares | superseded | [clm_EF5CD881E5C6](/claim/clm_EF5CD881E5C6.md)
- 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 14,603,000,000 United States dollar | superseded | [clm_996D653BDA3C](/claim/clm_996D653BDA3C.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_net_income | 1,605,000,000 United States dollar | superseded | [clm_A48C7F92F611](/claim/clm_A48C7F92F611.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_research_and_development | 1,796,000,000 United States dollar | superseded | [clm_9AA36D1C5BA9](/claim/clm_9AA36D1C5BA9.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 14,462,000,000 United States dollar | superseded | [clm_C7FEFC37896D](/claim/clm_C7FEFC37896D.md)
- 2024-03-31 to 2024-06-30 | money | shares_outstanding | 918,602,666 shares | superseded | [clm_1E088016FBBA](/claim/clm_1E088016FBBA.md)
- 2024-03-31 to 2024-06-30 | money | total_assets | 137,169,000,000 United States dollar | superseded | [clm_F4CFA7E5A525](/claim/clm_F4CFA7E5A525.md)
- 2024-03-31 to 2024-06-30 | money | total_equity | 23,261,000,000 United States dollar | superseded | [clm_EE638009F288](/claim/clm_EE638009F288.md)
- 2024-04-05 | other | hf_repo_created | ibm-granite/granite-timeseries-ttm-r1 | valid | [clm_C581127FB0AF](/claim/clm_C581127FB0AF.md)
- 2024-04-19 | other | hf_repo_created | ibm-granite/granite-7b-base | valid | [clm_61D1AA46B36A](/claim/clm_61D1AA46B36A.md)
- 2024-04-21 | other | hf_repo_created | ibm-granite/granite-8b-code-base-4k | valid | [clm_15CFD2AF19AE](/claim/clm_15CFD2AF19AE.md)
- 2024-04-21 | other | hf_repo_created | ibm-granite/granite-20b-code-base-8k | valid | [clm_2F0F664B5A39](/claim/clm_2F0F664B5A39.md)
- 2024-04-21 | other | hf_repo_created | ibm-granite/granite-34b-code-base-8k | valid | [clm_6268F779906C](/claim/clm_6268F779906C.md)
- 2024-04-23 | other | hf_repo_created | ibm-granite/granite-3b-code-base-2k | valid | [clm_E52E93FF73C2](/claim/clm_E52E93FF73C2.md)
- 2024-04-26 | other | hf_repo_created | ibm-granite/granite-34b-code-instruct-8k | valid | [clm_63A4DA0323AF](/claim/clm_63A4DA0323AF.md)
- 2024-04-26 | other | hf_repo_created | ibm-granite/granite-8b-code-instruct-4k | valid | [clm_8D00DDF077C6](/claim/clm_8D00DDF077C6.md)
- 2024-04-26 | other | hf_repo_created | ibm-granite/granite-3b-code-instruct-2k | valid | [clm_D443B34803D1](/claim/clm_D443B34803D1.md)
- 2024-04-26 | other | hf_repo_created | ibm-granite/granite-20b-code-instruct-8k | valid | [clm_E1BA431260B6](/claim/clm_E1BA431260B6.md)
- 2024-05-19 | other | hf_repo_created | ibm-granite/granite-7b-instruct | valid | [clm_AC0AAF8DED9B](/claim/clm_AC0AAF8DED9B.md)
- 2024-05-19 | other | hf_repo_created | ibm-granite/granite-20b-code-base-8k-GGUF | valid | [clm_D4FE08DD92F9](/claim/clm_D4FE08DD92F9.md)
- 2024-05-20 | other | hf_repo_created | ibm-granite/granite-20b-code-instruct-accelerator | valid | [clm_06272F34E9B7](/claim/clm_06272F34E9B7.md)
- 2024-05-20 | other | hf_repo_created | ibm-granite/granite-7b-instruct-accelerator | valid | [clm_2D7E902702B2](/claim/clm_2D7E902702B2.md)
- 2024-05-20 | other | hf_repo_created | ibm-granite/granite-34b-code-base-8k-GGUF | valid | [clm_6A46B26E4877](/claim/clm_6A46B26E4877.md)
- 2024-05-20 | other | hf_repo_created | ibm-granite/granite-34b-code-instruct-8k-GGUF | valid | [clm_C764DCB7DDDE](/claim/clm_C764DCB7DDDE.md)
- 2024-05-20 | other | hf_repo_created | ibm-granite/granite-20b-code-instruct-8k-GGUF | valid | [clm_FF95C1C76632](/claim/clm_FF95C1C76632.md)
- 2024-05-29 | other | hf_repo_created | ibm-granite/granite-8b-code-instruct-accelerator | valid | [clm_068A81160DFF](/claim/clm_068A81160DFF.md)
- 2024-05-29 | other | hf_repo_created | ibm-granite/granite-3b-code-instruct-2k-GGUF | valid | [clm_3296731545B6](/claim/clm_3296731545B6.md)
- 2024-05-29 | other | hf_repo_created | ibm-granite/granite-3b-code-base-2k-GGUF | valid | [clm_BFC72A8EEA64](/claim/clm_BFC72A8EEA64.md)
- 2024-05-30 | other | hf_repo_created | ibm-granite/granite-8b-code-base-4k-GGUF | valid | [clm_9604E45EA246](/claim/clm_9604E45EA246.md)
- 2024-05-30 | other | hf_repo_created | ibm-granite/granite-8b-code-instruct-4k-GGUF | valid | [clm_FEDE54519D7E](/claim/clm_FEDE54519D7E.md)
- 2024-06-12 | other | hf_repo_created | ibm-granite/granite-3b-code-instruct-accelerator | valid | [clm_F2267E8AC55A](/claim/clm_F2267E8AC55A.md)
- 2024-06-27 | other | hf_repo_created | ibm-granite/granite-geospatial-biomass | valid | [clm_BA8447AE7930](/claim/clm_BA8447AE7930.md)
- 2024-06-29 | other | hf_repo_created | ibm-granite/granite-3b-code-base-128k | valid | [clm_25D743465FA6](/claim/clm_25D743465FA6.md)
- 2024-06-29 | other | hf_repo_created | ibm-granite/granite-8b-code-base-128k | valid | [clm_862812CB1258](/claim/clm_862812CB1258.md)
- 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 12,210,000,000 United States dollar | superseded | [clm_E01D899767C6](/claim/clm_E01D899767C6.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_net_income | 1,834,000,000 United States dollar | superseded | [clm_C14468FAF2CB](/claim/clm_C14468FAF2CB.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_research_and_development | 1,840,000,000 United States dollar | superseded | [clm_7391E32B2E36](/claim/clm_7391E32B2E36.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 15,770,000,000 United States dollar | superseded | [clm_0F0E236C6FC6](/claim/clm_0F0E236C6FC6.md)
- 2024-06-30 to 2024-09-30 | money | shares_outstanding | 921,148,195 shares | superseded | [clm_F6D94C070054](/claim/clm_F6D94C070054.md)
- 2024-06-30 to 2024-09-30 | money | total_assets | 133,848,000,000 United States dollar | superseded | [clm_41E9303A00B8](/claim/clm_41E9303A00B8.md)
- 2024-06-30 to 2024-09-30 | money | total_equity | 24,026,000,000 United States dollar | superseded | [clm_61892D804A5D](/claim/clm_61892D804A5D.md)
- 2024-07-09 | other | hf_repo_created | ibm-granite/granite-20b-code-instruct-r1.1 | valid | [clm_7D2DAF01FF89](/claim/clm_7D2DAF01FF89.md)
- 2024-07-09 | other | hf_repo_created | ibm-granite/granite-20b-code-base-r1.1 | valid | [clm_B097FF517A08](/claim/clm_B097FF517A08.md)
- 2024-07-09 | other | hf_repo_created | ibm-granite/granite-20b-functioncalling | valid | [clm_FA7439E90856](/claim/clm_FA7439E90856.md)
- 2024-07-12 | other | hf_repo_created | ibm-granite/granite-8b-code-instruct-128k | valid | [clm_AB1E11F79C5D](/claim/clm_AB1E11F79C5D.md)
- 2024-07-12 | other | hf_repo_created | ibm-granite/granite-3b-code-instruct-128k | valid | [clm_E3F2CF15603A](/claim/clm_E3F2CF15603A.md)
- 2024-07-24 | other | hf_repo_created | ibm-granite/granite-34b-code-instruct-accelerator | valid | [clm_62D0A467F2A5](/claim/clm_62D0A467F2A5.md)
- 2024-09-05 | other | hf_repo_created | ibm-granite/granite-guardian-hap-38m | valid | [clm_A23099E711A2](/claim/clm_A23099E711A2.md)
- 2024-09-05 | other | hf_repo_created | ibm-granite/granite-guardian-hap-125m | valid | [clm_DF768FE4E39E](/claim/clm_DF768FE4E39E.md)
- 2024-09-20 | other | hf_repo_created | ibm-granite/granite-geospatial-wxc-downscaling | valid | [clm_DFA4547690E7](/claim/clm_DFA4547690E7.md)
- 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 13,197,000,000 United States dollar | superseded | [clm_45624D468C0F](/claim/clm_45624D468C0F.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_net_income | -330,000,000 United States dollar | superseded | [clm_62944C2FBD9E](/claim/clm_62944C2FBD9E.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_research_and_development | 1,876,000,000 United States dollar | superseded | [clm_56C4997C2631](/claim/clm_56C4997C2631.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 14,968,000,000 United States dollar | superseded | [clm_7B7B7DF58072](/claim/clm_7B7B7DF58072.md)
- 2024-09-30 to 2025-02-10 | money | shares_outstanding | 924,645,152 shares | superseded | [clm_1C5124C63B70](/claim/clm_1C5124C63B70.md)
- 2024-09-30 to 2024-12-31 | money | total_assets | 134,339,000,000 United States dollar | superseded | [clm_B0BEB13341B5](/claim/clm_B0BEB13341B5.md)
- 2024-09-30 to 2024-12-31 | money | total_equity | 24,448,000,000 United States dollar | superseded | [clm_E819485ECFBD](/claim/clm_E819485ECFBD.md)
- 2024-10-02 | other | hf_repo_created | ibm-granite/granite-3.0-2b-instruct | valid | [clm_06406CF06CB6](/claim/clm_06406CF06CB6.md)
- 2024-10-02 | other | hf_repo_created | ibm-granite/granite-3.0-8b-instruct | valid | [clm_15A870CDD24B](/claim/clm_15A870CDD24B.md)
- 2024-10-02 | other | hf_repo_created | ibm-granite/granite-3.0-2b-base | valid | [clm_5C5EA2FDB370](/claim/clm_5C5EA2FDB370.md)
- 2024-10-02 | other | hf_repo_created | ibm-granite/granite-3.0-8b-base | valid | [clm_5E493880C373](/claim/clm_5E493880C373.md)
- 2024-10-03 | other | hf_repo_created | ibm-granite/granite-3.0-3b-a800m-base | valid | [clm_1567C50E1AEA](/claim/clm_1567C50E1AEA.md)
- 2024-10-03 | other | hf_repo_created | ibm-granite/granite-3.0-3b-a800m-instruct | valid | [clm_1B5E44290FE0](/claim/clm_1B5E44290FE0.md)
- 2024-10-03 | other | hf_repo_created | ibm-granite/granite-3.0-1b-a400m-base | valid | [clm_38C709B23311](/claim/clm_38C709B23311.md)
- 2024-10-03 | other | hf_repo_created | ibm-granite/granite-3.0-1b-a400m-instruct | valid | [clm_55EB74F05039](/claim/clm_55EB74F05039.md)
- 2024-10-08 | other | hf_repo_created | ibm-granite/granite-timeseries-ttm-r2 | valid | [clm_45B611BA6B16](/claim/clm_45B611BA6B16.md)
- 2024-10-15 | other | hf_repo_created | ibm-granite/granite-guardian-3.0-2b | valid | [clm_563299FD2087](/claim/clm_563299FD2087.md)
- 2024-10-15 | other | hf_repo_created | ibm-granite/granite-guardian-3.0-8b | valid | [clm_C8C972E54534](/claim/clm_C8C972E54534.md)
- 2024-10-16 | other | hf_repo_created | ibm-granite/granite-3.0-8b-instruct-accelerator | valid | [clm_F17F40B62C6F](/claim/clm_F17F40B62C6F.md)
- 2024-10-21 | other | hf_repo_created | ibm-granite/granite-uncertainty-3.0-8b-lora | valid | [clm_27100B2B1B39](/claim/clm_27100B2B1B39.md)
- 2024-10-21 | money | partnership | [Ollama](/record/ollama.md) | unverified | [clm_E8F0C7DCD158](/claim/clm_E8F0C7DCD158.md)
- 2024-10-21 | products | released | IBM Granite 3.0 | unverified | [clm_31B783182ECE](/claim/clm_31B783182ECE.md)
- 2024-11-01 | other | hf_repo_created | ibm-granite/granite-rag-3.0-8b-lora | valid | [clm_36F197E56DCE](/claim/clm_36F197E56DCE.md)
- 2024-11-05 | other | hf_repo_created | ibm-granite/granite-geospatial-land-surface-temperature | valid | [clm_1682C11A60DB](/claim/clm_1682C11A60DB.md)
- 2024-11-05 | other | hf_repo_created | ibm-granite/granite-geospatial-canopyheight | valid | [clm_4C5CBE9A7775](/claim/clm_4C5CBE9A7775.md)
- 2024-12-03 | other | hf_repo_created | ibm-granite/granite-geospatial-uki | valid | [clm_360205442AB5](/claim/clm_360205442AB5.md)
- 2024-12-03 | other | hf_repo_created | ibm-granite/granite-geospatial-uki-flooddetection | valid | [clm_EEF6A2A1AAF1](/claim/clm_EEF6A2A1AAF1.md)
- 2024-12-04 | other | hf_repo_created | ibm-granite/granite-embedding-107m-multilingual | valid | [clm_868EE4B11B32](/claim/clm_868EE4B11B32.md)
- 2024-12-04 | other | hf_repo_created | ibm-granite/granite-embedding-30m-english | valid | [clm_BFE93C1E2642](/claim/clm_BFE93C1E2642.md)
- 2024-12-04 | other | hf_repo_created | ibm-granite/granite-embedding-125m-english | valid | [clm_D5F507CF2F8F](/claim/clm_D5F507CF2F8F.md)
- 2024-12-04 | other | hf_repo_created | ibm-granite/granite-embedding-278m-multilingual | valid | [clm_DCD5F1108367](/claim/clm_DCD5F1108367.md)
- 2024-12-06 | other | hf_repo_created | ibm-granite/granite-3.1-3b-a800m-base | valid | [clm_37E20B438813](/claim/clm_37E20B438813.md)
- 2024-12-06 | other | hf_repo_created | ibm-granite/granite-3.1-1b-a400m-instruct | valid | [clm_471CF1520F7C](/claim/clm_471CF1520F7C.md)
- 2024-12-06 | other | hf_repo_created | ibm-granite/granite-3.1-2b-base | valid | [clm_887E0F4C5C24](/claim/clm_887E0F4C5C24.md)
- 2024-12-06 | other | hf_repo_created | ibm-granite/granite-3.1-8b-instruct | valid | [clm_892B2C081EF4](/claim/clm_892B2C081EF4.md)
- 2024-12-06 | other | hf_repo_created | ibm-granite/granite-3.1-3b-a800m-instruct | valid | [clm_A7193D806E02](/claim/clm_A7193D806E02.md)
- 2024-12-06 | other | hf_repo_created | ibm-granite/granite-3.1-1b-a400m-base | valid | [clm_AE4CC5DCDF50](/claim/clm_AE4CC5DCDF50.md)
- 2024-12-06 | other | hf_repo_created | ibm-granite/granite-3.1-2b-instruct | valid | [clm_C580695BCFA7](/claim/clm_C580695BCFA7.md)
- 2024-12-06 | other | hf_repo_created | ibm-granite/granite-3.1-8b-base | valid | [clm_F9A5658261C4](/claim/clm_F9A5658261C4.md)
- 2024-12-07 | other | hf_repo_created | ibm-granite/granite-3.0-8b-lora-intrinsics-v0.1 | valid | [clm_3CAD2704D684](/claim/clm_3CAD2704D684.md)
- 2024-12-17 | other | hf_repo_created | ibm-granite/granite-3.1-8b-lora-intrinsics-v0.1 | valid | [clm_1A18BF3847F3](/claim/clm_1A18BF3847F3.md)
- 2024-12-17 | other | hf_repo_created | ibm-granite/granite-guardian-3.1-2b | valid | [clm_1F17111AC67D](/claim/clm_1F17111AC67D.md)
- 2024-12-17 | other | hf_repo_created | ibm-granite/granite-guardian-3.1-8b | valid | [clm_A372B447B272](/claim/clm_A372B447B272.md)
- 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 13,947,000,000 United States dollar | superseded | [clm_DC1F6A4E5044](/claim/clm_DC1F6A4E5044.md)
- 2024-12-31 to 2025-12-31 | money | net_income | 6,023,000,000 United States dollar | superseded | [clm_BC2F24BA080C](/claim/clm_BC2F24BA080C.md)
- 2024-12-31 to 2025-12-31 | money | research_and_development | 7,479,000,000 United States dollar | superseded | [clm_BA96463B514F](/claim/clm_BA96463B514F.md)
- 2024-12-31 to 2025-12-31 | money | revenue | 62,753,000,000 United States dollar | superseded | [clm_97AA9312DADA](/claim/clm_97AA9312DADA.md)
- 2024-12-31 to 2025-03-31 | money | total_assets | 137,175,000,000 United States dollar | superseded | [clm_E87F238FA937](/claim/clm_E87F238FA937.md)
- 2024-12-31 to 2025-03-31 | money | total_equity | 27,307,000,000 United States dollar | superseded | [clm_4B202BF4E772](/claim/clm_4B202BF4E772.md)

## 2025

- 2025-01-23 | other | hf_repo_created | ibm-granite/granite-guardian-3.2-5b | valid | [clm_BC07EA332BCB](/claim/clm_BC07EA332BCB.md)
- 2025-01-27 | other | hf_repo_created | ibm-granite/granite-vision-3.1-2b-preview | valid | [clm_0BAC836967AE](/claim/clm_0BAC836967AE.md)
- 2025-02-03 | other | hf_repo_created | ibm-granite/granite-guardian-3.2-3b-a800m | valid | [clm_8CAAE026542E](/claim/clm_8CAAE026542E.md)
- 2025-02-07 | other | hf_repo_created | ibm-granite/granite-3.2-8b-instruct-preview | valid | [clm_DA41EAC1B5C4](/claim/clm_DA41EAC1B5C4.md)
- 2025-02-10 to 2025-03-31 | money | shares_outstanding | 927,264,332 shares | superseded | [clm_0EDC4C3EE82F](/claim/clm_0EDC4C3EE82F.md)
- 2025-02-12 | other | hf_repo_created | ibm-granite/GneissWeb.Med_classifier | valid | [clm_206C73A94971](/claim/clm_206C73A94971.md)
- 2025-02-12 | other | hf_repo_created | ibm-granite/GneissWeb.Quality_annotator | valid | [clm_8CF6CD22EB31](/claim/clm_8CF6CD22EB31.md)
- 2025-02-12 | other | hf_repo_created | ibm-granite/GneissWeb.Tech_classifier | valid | [clm_916DC9533F26](/claim/clm_916DC9533F26.md)
- 2025-02-12 | other | hf_repo_created | ibm-granite/GneissWeb.Edu_classifier | valid | [clm_C642F4BDCB0B](/claim/clm_C642F4BDCB0B.md)
- 2025-02-12 | other | hf_repo_created | ibm-granite/GneissWeb.Sci_classifier | valid | [clm_CB9021281DD6](/claim/clm_CB9021281DD6.md)
- 2025-02-12 | other | hf_repo_created | ibm-granite/GneissWeb.bloom | valid | [clm_E2584B6285B8](/claim/clm_E2584B6285B8.md)
- 2025-02-17 | other | hf_repo_created | ibm-granite/granite-vision-3.2-2b | valid | [clm_A9A8B7323603](/claim/clm_A9A8B7323603.md)
- 2025-02-17 | other | hf_repo_created | ibm-granite/granite-3.2-8b-instruct | valid | [clm_ABA1EFF468DE](/claim/clm_ABA1EFF468DE.md)
- 2025-02-17 | other | hf_repo_created | ibm-granite/granite-embedding-30m-sparse | valid | [clm_E390789796E2](/claim/clm_E390789796E2.md)
- 2025-02-17 | other | hf_repo_created | ibm-granite/granite-3.2-2b-instruct | valid | [clm_EECE4894AA4E](/claim/clm_EECE4894AA4E.md)
- 2025-02-22 | other | hf_repo_created | ibm-granite/GneissWeb.7B_ablation_model_on_350B_FineWeb.seed1 | valid | [clm_8346D5721B5F](/claim/clm_8346D5721B5F.md)
- 2025-02-22 | other | hf_repo_created | ibm-granite/GneissWeb.7B_ablation_model_on_350B_FineWeb.Edu.seed1 | valid | [clm_C72B7182AD68](/claim/clm_C72B7182AD68.md)
- 2025-02-22 | other | hf_repo_created | ibm-granite/GneissWeb.7B_ablation_model_on_350B_GneissWeb.seed1 | valid | [clm_D6C42A737BB4](/claim/clm_D6C42A737BB4.md)
- 2025-02-28 | other | hf_repo_created | ibm-granite/GneissWeb.7B_ablation_model_on_350B_GneissWeb.seed2 | valid | [clm_532E9221F4A6](/claim/clm_532E9221F4A6.md)
- 2025-02-28 | other | hf_repo_created | ibm-granite/GneissWeb.7B_ablation_model_on_350B_FineWeb.Edu.seed3 | valid | [clm_88364E3729ED](/claim/clm_88364E3729ED.md)
- 2025-02-28 | other | hf_repo_created | ibm-granite/GneissWeb.7B_ablation_model_on_350B_FineWeb.seed2 | valid | [clm_D91CDC927EE5](/claim/clm_D91CDC927EE5.md)
- 2025-02-28 | other | hf_repo_created | ibm-granite/GneissWeb.7B_ablation_model_on_350B_FineWeb.Edu.seed2 | valid | [clm_EA07CD69490B](/claim/clm_EA07CD69490B.md)
- 2025-02-28 | other | hf_repo_created | ibm-granite/GneissWeb.7B_ablation_model_on_350B_GneissWeb.seed3 | valid | [clm_EBCE32A5E06F](/claim/clm_EBCE32A5E06F.md)
- 2025-02-28 | other | hf_repo_created | ibm-granite/GneissWeb.7B_ablation_model_on_350B_FineWeb.seed3 | valid | [clm_FCBB6D7588A1](/claim/clm_FCBB6D7588A1.md)
- 2025-03-26 | other | hf_repo_created | ibm-granite/granite-speech-3.2-8b | valid | [clm_4B844F2BAB70](/claim/clm_4B844F2BAB70.md)
- 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 11,035,000,000 United States dollar | superseded | [clm_41BCA0EA87E2](/claim/clm_41BCA0EA87E2.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_net_income | 1,055,000,000 United States dollar | superseded | [clm_E28B7BF8890D](/claim/clm_E28B7BF8890D.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_research_and_development | 1,950,000,000 United States dollar | superseded | [clm_673177A1BFFA](/claim/clm_673177A1BFFA.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 14,541,000,000 United States dollar | superseded | [clm_50417DF14A34](/claim/clm_50417DF14A34.md)
- 2025-03-31 to 2025-06-30 | money | shares_outstanding | 929,396,575 shares | superseded | [clm_A18997B7527C](/claim/clm_A18997B7527C.md)
- 2025-03-31 to 2025-06-30 | money | total_assets | 145,667,000,000 United States dollar | superseded | [clm_9D16429EB54A](/claim/clm_9D16429EB54A.md)
- 2025-03-31 to 2025-06-30 | money | total_equity | 26,880,000,000 United States dollar | superseded | [clm_9EFA1F4495A4](/claim/clm_9EFA1F4495A4.md)
- 2025-04-01 | other | hf_repo_created | ibm-granite/granite-3.2-8b-lora-uncertainty | valid | [clm_58069ED89E5F](/claim/clm_58069ED89E5F.md)
- 2025-04-09 | other | hf_repo_created | ibm-granite/granite-3.3-8b-instruct | valid | [clm_04E31AFC809C](/claim/clm_04E31AFC809C.md)
- 2025-04-09 | other | hf_repo_created | ibm-granite/granite-3.3-8b-base | valid | [clm_0EBC0C3323C5](/claim/clm_0EBC0C3323C5.md)
- 2025-04-09 | other | hf_repo_created | ibm-granite/granite-3.3-2b-instruct | valid | [clm_139D51AA4F2D](/claim/clm_139D51AA4F2D.md)
- 2025-04-09 | other | hf_repo_created | ibm-granite/granite-3.3-2b-base | valid | [clm_94E19489F3DA](/claim/clm_94E19489F3DA.md)
- 2025-04-11 | other | hf_repo_created | ibm-granite/granite-3.3-8b-instruct-GGUF | valid | [clm_63E335CE4F65](/claim/clm_63E335CE4F65.md)
- 2025-04-11 | other | hf_repo_created | ibm-granite/granite-3.2-8b-lora-rag-citation-generation | valid | [clm_9468692012B1](/claim/clm_9468692012B1.md)
- 2025-04-11 | other | hf_repo_created | ibm-granite/granite-3.3-2b-instruct-GGUF | valid | [clm_EA77A260A804](/claim/clm_EA77A260A804.md)
- 2025-04-14 | other | hf_repo_created | ibm-granite/granite-3.2-8b-alora-jailbreak | valid | [clm_16E51ABCC6CC](/claim/clm_16E51ABCC6CC.md)
- 2025-04-14 | other | hf_repo_created | ibm-granite/granite-3.2-8b-alora-rag-query-rewrite | valid | [clm_39859EF14825](/claim/clm_39859EF14825.md)
- 2025-04-14 | other | hf_repo_created | ibm-granite/granite-speech-3.3-8b | valid | [clm_8C819F189DFF](/claim/clm_8C819F189DFF.md)
- 2025-04-14 | other | hf_repo_created | ibm-granite/granite-3.2-8b-lora-jailbreak | valid | [clm_90EFF66A3798](/claim/clm_90EFF66A3798.md)
- 2025-04-22 | other | hf_repo_created | ibm-granite/granite-3.2-8b-alora-requirement-check | valid | [clm_C50F58B375EB](/claim/clm_C50F58B375EB.md)
- 2025-04-28 | other | hf_repo_created | ibm-granite/granite-speech-3.3-2b | valid | [clm_0D6FA91B6085](/claim/clm_0D6FA91B6085.md)
- 2025-04-30 | other | hf_repo_created | ibm-granite/granite-4.0-tiny-base-preview | valid | [clm_438EF4E0398B](/claim/clm_438EF4E0398B.md)
- 2025-04-30 | other | hf_repo_created | ibm-granite/granite-4.0-tiny-preview | valid | [clm_5AA2BDFE15E9](/claim/clm_5AA2BDFE15E9.md)
- 2025-05-02 | other | hf_repo_created | ibm-granite/granite-3.3-2b-base-GGUF | valid | [clm_121053203DFE](/claim/clm_121053203DFE.md)
- 2025-05-02 | other | hf_repo_created | ibm-granite/granite-3.3-8b-base-GGUF | valid | [clm_C48B6CC18F4E](/claim/clm_C48B6CC18F4E.md)
- 2025-05-19 | other | hf_repo_created | ibm-granite/granite-docling-258M | valid | [clm_1F912F1CBC25](/claim/clm_1F912F1CBC25.md)
- 2025-06-03 | other | hf_repo_created | ibm-granite/granite-vision-3.3-2b-embedding | valid | [clm_3BFB76E7F196](/claim/clm_3BFB76E7F196.md)
- 2025-06-03 | other | hf_repo_created | ibm-granite/granite-timeseries-tspulse-r1 | valid | [clm_8DEBAEC3DB74](/claim/clm_8DEBAEC3DB74.md)
- 2025-06-03 | other | hf_repo_created | ibm-granite/granite-guardian-3.3-8b | valid | [clm_B79C697254DB](/claim/clm_B79C697254DB.md)
- 2025-06-03 | other | hf_repo_created | ibm-granite/granite-vision-3.3-2b | valid | [clm_CC1C4EA36599](/claim/clm_CC1C4EA36599.md)
- 2025-06-07 | other | hf_repo_created | ibm-granite/granite-3.3-8b-alora-uncertainty | valid | [clm_41E4CE7D6F95](/claim/clm_41E4CE7D6F95.md)
- 2025-06-09 | other | hf_repo_created | ibm-granite/granite-3.3-8b-rag-agent-lib | valid | [clm_D87416DB8510](/claim/clm_D87416DB8510.md)
- 2025-06-16 | other | hf_repo_created | ibm-granite/granite-3.3-8b-lora-math-prm | valid | [clm_B1DEFF0CB449](/claim/clm_B1DEFF0CB449.md)
- 2025-06-19 | other | hf_repo_created | ibm-granite/granite-3.3-8b-alora-requirement-check | valid | [clm_6399C74CC9E2](/claim/clm_6399C74CC9E2.md)
- 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 11,943,000,000 United States dollar | superseded | [clm_14DF8C0AAD45](/claim/clm_14DF8C0AAD45.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_net_income | 2,194,000,000 United States dollar | superseded | [clm_AF11D1A85E7B](/claim/clm_AF11D1A85E7B.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_research_and_development | 2,097,000,000 United States dollar | superseded | [clm_82E0D1B5716E](/claim/clm_82E0D1B5716E.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 16,977,000,000 United States dollar | superseded | [clm_9499E30D6818](/claim/clm_9499E30D6818.md)
- 2025-06-30 to 2025-09-30 | money | shares_outstanding | 931,519,242 shares | superseded | [clm_A700BAB7FAFE](/claim/clm_A700BAB7FAFE.md)
- 2025-06-30 to 2025-09-30 | money | total_assets | 148,585,000,000 United States dollar | superseded | [clm_4F24C1FCECCD](/claim/clm_4F24C1FCECCD.md)
- 2025-06-30 to 2025-09-30 | money | total_equity | 27,509,000,000 United States dollar | superseded | [clm_4965787EC4BC](/claim/clm_4965787EC4BC.md)
- 2025-07-08 | other | hf_repo_created | ibm-granite/granite-docling-258M-mlx | valid | [clm_BC5823BAC758](/claim/clm_BC5823BAC758.md)
- 2025-07-17 | other | hf_repo_created | ibm-granite/granite-embedding-small-english-r2 | valid | [clm_06B5BA2F8B51](/claim/clm_06B5BA2F8B51.md)
- 2025-07-17 | other | hf_repo_created | ibm-granite/granite-embedding-english-r2 | valid | [clm_7AF6F8EA2C44](/claim/clm_7AF6F8EA2C44.md)
- 2025-07-30 | other | hf_repo_created | ibm-granite/rag-intrinsics-lib | valid | [clm_DBD980807E16](/claim/clm_DBD980807E16.md)
- 2025-08-04 | other | hf_repo_created | ibm-granite/granite-embedding-reranker-english-r2 | valid | [clm_CA396CA6A820](/claim/clm_CA396CA6A820.md)
- 2025-08-12 | other | hf_repo_created | ibm-granite/granite-guardian-3.3-8b-GGUF | valid | [clm_13EBA6AF6A4D](/claim/clm_13EBA6AF6A4D.md)
- 2025-08-12 | other | hf_repo_created | ibm-granite/granite-4.0-tiny-base-preview-GGUF | valid | [clm_98C00CA32393](/claim/clm_98C00CA32393.md)
- 2025-08-12 | other | hf_repo_created | ibm-granite/granite-vision-3.3-2b-GGUF | valid | [clm_AA9CE1FEAF3C](/claim/clm_AA9CE1FEAF3C.md)
- 2025-08-12 | other | hf_repo_created | ibm-granite/granite-4.0-tiny-preview-GGUF | valid | [clm_E82350C37AE8](/claim/clm_E82350C37AE8.md)
- 2025-08-28 | other | hf_repo_created | ibm-granite/granite-guardian-3.2-5b-lora-harm-correction | valid | [clm_7AF7E63E0A93](/claim/clm_7AF7E63E0A93.md)
- 2025-08-28 | other | hf_repo_created | ibm-granite/granite-guardian-3.2-5b-lora-harm-categories | valid | [clm_F1AB89AED3DD](/claim/clm_F1AB89AED3DD.md)
- 2025-09-10 | other | hf_repo_created | ibm-granite/granite-timeseries-flowstate-r1 | valid | [clm_7A4B4D5A763D](/claim/clm_7A4B4D5A763D.md)
- 2025-09-16 | other | hf_repo_created | ibm-granite/granite-4.0-h-small-base | valid | [clm_1FF00758B217](/claim/clm_1FF00758B217.md)
- 2025-09-16 | other | hf_repo_created | ibm-granite/granite-4.0-h-tiny-base | valid | [clm_28B8043216FE](/claim/clm_28B8043216FE.md)
- 2025-09-16 | other | hf_repo_created | ibm-granite/granite-4.0-h-micro | valid | [clm_38E1E879AD55](/claim/clm_38E1E879AD55.md)
- 2025-09-16 | other | hf_repo_created | ibm-granite/granite-geospatial-ocean | valid | [clm_4B1768A308D4](/claim/clm_4B1768A308D4.md)
- 2025-09-16 | other | hf_repo_created | ibm-granite/granite-4.0-h-tiny | valid | [clm_59B1AC94AA73](/claim/clm_59B1AC94AA73.md)
- 2025-09-16 | other | hf_repo_created | ibm-granite/granite-4.0-h-micro-base | valid | [clm_74DAFBE7A521](/claim/clm_74DAFBE7A521.md)
- 2025-09-16 | other | hf_repo_created | ibm-granite/granite-4.0-h-small | valid | [clm_94F0B3A5377D](/claim/clm_94F0B3A5377D.md)
- 2025-09-16 | other | hf_repo_created | ibm-granite/granite-4.0-micro-base | valid | [clm_D3A9ECBAA75F](/claim/clm_D3A9ECBAA75F.md)
- 2025-09-16 | other | hf_repo_created | ibm-granite/granite-4.0-micro | valid | [clm_D595481E38AB](/claim/clm_D595481E38AB.md)
- 2025-09-24 | other | hf_repo_created | ibm-granite/granite-4.0-micro-base-GGUF | valid | [clm_47B83300A1D0](/claim/clm_47B83300A1D0.md)
- 2025-09-24 | other | hf_repo_created | ibm-granite/granite-4.0-micro-GGUF | valid | [clm_4AD98D0B6E5E](/claim/clm_4AD98D0B6E5E.md)
- 2025-09-24 | other | hf_repo_created | ibm-granite/granite-4.0-h-tiny-GGUF | valid | [clm_59ECB10D84F9](/claim/clm_59ECB10D84F9.md)
- 2025-09-24 | other | hf_repo_created | ibm-granite/granite-4.0-h-micro-base-GGUF | valid | [clm_7D1A43FB7B0C](/claim/clm_7D1A43FB7B0C.md)
- 2025-09-24 | other | hf_repo_created | ibm-granite/granite-4.0-h-tiny-base-GGUF | valid | [clm_CA848C47748E](/claim/clm_CA848C47748E.md)
- 2025-09-24 | other | hf_repo_created | ibm-granite/granite-4.0-h-micro-GGUF | valid | [clm_FB90D78AE772](/claim/clm_FB90D78AE772.md)
- 2025-09-25 | other | hf_repo_created | ibm-granite/granite-4.0-h-small-base-GGUF | valid | [clm_08339773ED67](/claim/clm_08339773ED67.md)
- 2025-09-25 | other | hf_repo_created | ibm-granite/granite-4.0-h-small-GGUF | valid | [clm_5F3D7DB1F700](/claim/clm_5F3D7DB1F700.md)
- 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 11,569,000,000 United States dollar | superseded | [clm_712CD4B090E3](/claim/clm_712CD4B090E3.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_net_income | 1,744,000,000 United States dollar | superseded | [clm_B161DCD2A109](/claim/clm_B161DCD2A109.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_research_and_development | 2,082,000,000 United States dollar | superseded | [clm_971C957BC3AB](/claim/clm_971C957BC3AB.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 16,331,000,000 United States dollar | superseded | [clm_5C5736C13D18](/claim/clm_5C5736C13D18.md)
- 2025-09-30 to 2026-02-10 | money | shares_outstanding | 934,735,206 shares | superseded | [clm_B81EB0A1FE8F](/claim/clm_B81EB0A1FE8F.md)
- 2025-09-30 to 2025-12-31 | money | total_assets | 146,312,000,000 United States dollar | superseded | [clm_B6D648138541](/claim/clm_B6D648138541.md)
- 2025-09-30 to 2025-12-31 | money | total_equity | 27,905,000,000 United States dollar | superseded | [clm_E19933E9A539](/claim/clm_E19933E9A539.md)
- 2025-10-01 | other | hf_repo_created | ibm-granite/granite-4.0-h-small-FP8 | valid | [clm_DB4056797742](/claim/clm_DB4056797742.md)
- 2025-10-07 | other | hf_repo_created | ibm-granite/granite-4.0-1b-base | valid | [clm_260869745D63](/claim/clm_260869745D63.md)
- 2025-10-07 | other | hf_repo_created | ibm-granite/granite-4.0-h-1b | valid | [clm_354402E8AB02](/claim/clm_354402E8AB02.md)
- 2025-10-07 | other | hf_repo_created | ibm-granite/granite-3.3-8b-security-lib | valid | [clm_4200C762F7BF](/claim/clm_4200C762F7BF.md)
- 2025-10-07 | other | hf_repo_created | ibm-granite/granite-4.0-350m | valid | [clm_4E461EDD1318](/claim/clm_4E461EDD1318.md)
- 2025-10-07 | other | hf_repo_created | ibm-granite/granite-4.0-350m-base | valid | [clm_A521CAAD33F9](/claim/clm_A521CAAD33F9.md)
- 2025-10-07 | other | hf_repo_created | ibm-granite/granite-4.0-h-350m | valid | [clm_F486901969EA](/claim/clm_F486901969EA.md)
- 2025-10-07 | other | hf_repo_created | ibm-granite/granite-4.0-1b | valid | [clm_F5C92C231D9A](/claim/clm_F5C92C231D9A.md)
- 2025-10-07 | other | hf_repo_created | ibm-granite/granite-4.0-h-350m-base | valid | [clm_F82C055A9083](/claim/clm_F82C055A9083.md)
- 2025-10-07 | other | hf_repo_created | ibm-granite/granite-4.0-h-1b-base | valid | [clm_FD5CBF308016](/claim/clm_FD5CBF308016.md)
- 2025-10-16 | other | hf_repo_created | ibm-granite/granite-3.3-8b-instruct-FP8 | valid | [clm_3ADF4906AF79](/claim/clm_3ADF4906AF79.md)
- 2025-10-23 | other | hf_repo_created | ibm-granite/granite-docling-258M-GGUF | valid | [clm_1734341FF4FF](/claim/clm_1734341FF4FF.md)
- 2025-10-23 | other | hf_repo_created | ibm-granite/granite-4.0-1b-GGUF | valid | [clm_566418F37E34](/claim/clm_566418F37E34.md)
- 2025-10-23 | other | hf_repo_created | ibm-granite/granite-4.0-1b-base-GGUF | valid | [clm_5EE6B62E3130](/claim/clm_5EE6B62E3130.md)
- 2025-10-23 | other | hf_repo_created | ibm-granite/granite-4.0-h-350m-base-GGUF | valid | [clm_5FF4108BE04B](/claim/clm_5FF4108BE04B.md)
- 2025-10-23 | other | hf_repo_created | ibm-granite/granite-4.0-h-1b-base-GGUF | valid | [clm_79955C9A1470](/claim/clm_79955C9A1470.md)
- 2025-10-23 | other | hf_repo_created | ibm-granite/granite-4.0-h-1b-GGUF | valid | [clm_7B40B2712063](/claim/clm_7B40B2712063.md)
- 2025-10-23 | other | hf_repo_created | ibm-granite/granite-4.0-350m-GGUF | valid | [clm_B6D15D1ED4A4](/claim/clm_B6D15D1ED4A4.md)
- 2025-10-23 | other | hf_repo_created | ibm-granite/granite-4.0-350m-base-GGUF | valid | [clm_F10267D15798](/claim/clm_F10267D15798.md)
- 2025-10-23 | other | hf_repo_created | ibm-granite/granite-4.0-h-350m-GGUF | valid | [clm_FD09100DE0B8](/claim/clm_FD09100DE0B8.md)
- 2025-10-28 | models | model_release | Granite 4.0 Nano | unverified | [clm_1A7C99E8406C](/claim/clm_1A7C99E8406C.md)
- 2025-11-10 | other | hf_repo_created | ibm-granite/granite-guardian-3.2-8b-factuality-detection | valid | [clm_1C4342C2D6EF](/claim/clm_1C4342C2D6EF.md)
- 2025-11-10 | other | hf_repo_created | ibm-granite/granite-guardian-3.2-5b-lora-factuality-correction | valid | [clm_8D7D3D50452F](/claim/clm_8D7D3D50452F.md)
- 2025-12-08 | other | hf_repo_created | ibm-granite/granitelib-rag-r1.0 | valid | [clm_DD9C6DA08780](/claim/clm_DD9C6DA08780.md)
- 2025-12-10 | other | hf_repo_created | ibm-granite/granitelib-core-r1.0 | valid | [clm_C30FD71B1B3C](/claim/clm_C30FD71B1B3C.md)
- 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 13,587,000,000 United States dollar | superseded | [clm_CE8C5486D264](/claim/clm_CE8C5486D264.md)
- 2025-12-31 | money | employees | 264,300 | valid | [clm_202961D76868](/claim/clm_202961D76868.md)
- 2025-12-31 | money | net_income | 10,593,000,000 United States dollar | valid | [clm_6EA1A8B6EEF6](/claim/clm_6EA1A8B6EEF6.md)
- 2025-12-31 | money | research_and_development | 8,316,000,000 United States dollar | valid | [clm_FBF0FBAADE58](/claim/clm_FBF0FBAADE58.md)
- 2025-12-31 | money | revenue | 67,535,000,000 United States dollar | valid | [clm_D9E3D5A0E563](/claim/clm_D9E3D5A0E563.md)
- 2025-12-31 to 2026-03-31 | money | total_assets | 151,880,000,000 United States dollar | superseded | [clm_F278504C5911](/claim/clm_F278504C5911.md)
- 2025-12-31 to 2026-03-31 | money | total_equity | 32,648,000,000 United States dollar | superseded | [clm_FF155E2C9337](/claim/clm_FF155E2C9337.md)

## 2026

- 2026-01-07 | other | hf_repo_created | ibm-granite/granite-3.3-8b-math-prm-v2 | valid | [clm_2BC7D406BE48](/claim/clm_2BC7D406BE48.md)
- 2026-01-29 | other | hf_repo_created | ibm-granite/granite-vision-3.3-2b-chart2csv-preview | valid | [clm_67C7250FBFA5](/claim/clm_67C7250FBFA5.md)
- 2026-02-02 | other | hf_repo_created | ibm-granite/granitelib-guardian-r1.0 | valid | [clm_FCF3C83C229E](/claim/clm_FCF3C83C229E.md)
- 2026-02-10 to 2026-03-31 | money | shares_outstanding | 938,034,404 shares | superseded | [clm_F640247B6710](/claim/clm_F640247B6710.md)
- 2026-02-12 | other | hf_repo_created | ibm-granite/granitelib-rag-gpt-oss-r1.0 | valid | [clm_8E374FCA4BA7](/claim/clm_8E374FCA4BA7.md)
- 2026-02-27 | other | hf_repo_created | ibm-granite/granite-4.0-1b-speech | valid | [clm_908FB1CF23DB](/claim/clm_908FB1CF23DB.md)
- 2026-03-01 | people | board_member | [Ramon Laguarta](/record/ramon-laguarta.md) | valid | [clm_FF42BE48AA8B](/claim/clm_FF42BE48AA8B.md)
- 2026-03-03 | other | hf_repo_created | ibm-granite/granite-4.0-3b-vision | valid | [clm_0F90284EADBC](/claim/clm_0F90284EADBC.md)
- 2026-03-10 | other | hf_repo_created | ibm-granite/granite-speech-4.1-2b-nar | valid | [clm_722F3DA2FA3C](/claim/clm_722F3DA2FA3C.md)
- 2026-03-11 | other | hf_repo_created | ibm-granite/granite-timeseries-patchtst-fm-r1 | valid | [clm_AD2011DEE343](/claim/clm_AD2011DEE343.md)
- 2026-03-13 | other | hf_repo_created | ibm-granite/granite-vision-3.3-2b-chart2csv-preview-GGUF | valid | [clm_DED0E739D9E9](/claim/clm_DED0E739D9E9.md)
- 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 10,819,000,000 United States dollar | superseded | [clm_E2DD8F984B49](/claim/clm_E2DD8F984B49.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_net_income | 1,216,000,000 United States dollar | superseded | [clm_37B2BC24F575](/claim/clm_37B2BC24F575.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_research_and_development | 2,173,000,000 United States dollar | superseded | [clm_DC043BA5623F](/claim/clm_DC043BA5623F.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 15,917,000,000 United States dollar | superseded | [clm_157F761894CE](/claim/clm_157F761894CE.md)
- 2026-03-31 | products | released | Granite 4.0 3B Vision | unverified | [clm_DC9296F28516](/claim/clm_DC9296F28516.md)
- 2026-03-31 to 2026-06-30 | money | shares_outstanding | 939,885,280 shares | superseded | [clm_2076667993B5](/claim/clm_2076667993B5.md)
- 2026-03-31 to 2026-06-30 | money | total_assets | 156,229,000,000 United States dollar | superseded | [clm_9DE5FADB1506](/claim/clm_9DE5FADB1506.md)
- 2026-03-31 to 2026-06-30 | money | total_equity | 32,974,000,000 United States dollar | superseded | [clm_BF01506E055C](/claim/clm_BF01506E055C.md)
- 2026-04-06 | other | hf_repo_created | ibm-granite/granite-4.1-3b | valid | [clm_0191F447B537](/claim/clm_0191F447B537.md)
- 2026-04-06 | other | hf_repo_created | ibm-granite/granite-4.1-30b-base | valid | [clm_070F31DB239C](/claim/clm_070F31DB239C.md)
- 2026-04-06 | other | hf_repo_created | ibm-granite/granite-4.1-3b-base | valid | [clm_67AC90064A5F](/claim/clm_67AC90064A5F.md)
- 2026-04-06 | other | hf_repo_created | ibm-granite/granite-4.1-8b | valid | [clm_6ACD09C2077F](/claim/clm_6ACD09C2077F.md)
- 2026-04-06 | other | hf_repo_created | ibm-granite/granite-4.1-8b-base | valid | [clm_9BA5A9567BF0](/claim/clm_9BA5A9567BF0.md)
- 2026-04-06 | other | hf_repo_created | ibm-granite/granite-guardian-4.0-3b-toxicity-ja | valid | [clm_AAE1272FB592](/claim/clm_AAE1272FB592.md)
- 2026-04-06 | other | hf_repo_created | ibm-granite/granite-4.1-30b | valid | [clm_D379487DDE9F](/claim/clm_D379487DDE9F.md)
- 2026-04-16 | other | hf_repo_created | ibm-granite/granite-guardian-4.1-8b | valid | [clm_3E23E7EF7A78](/claim/clm_3E23E7EF7A78.md)
- 2026-04-16 | other | hf_repo_created | ibm-granite/granite-4.1-8b-GGUF | valid | [clm_6D8A89B5BCB7](/claim/clm_6D8A89B5BCB7.md)
- 2026-04-16 | other | hf_repo_created | ibm-granite/granite-4.1-3b-GGUF | valid | [clm_6E9C4E2D5F30](/claim/clm_6E9C4E2D5F30.md)
- 2026-04-16 | other | hf_repo_created | ibm-granite/granite-speech-4.1-2b | valid | [clm_789619416CE9](/claim/clm_789619416CE9.md)
- 2026-04-16 | other | hf_repo_created | ibm-granite/granite-speech-4.1-2b-plus | valid | [clm_9E44AC820A0A](/claim/clm_9E44AC820A0A.md)
- 2026-04-16 | other | hf_repo_created | ibm-granite/granite-vision-4.1-4b | valid | [clm_F4C165F6E3F7](/claim/clm_F4C165F6E3F7.md)
- 2026-04-17 | other | hf_repo_created | ibm-granite/granite-4.1-30b-GGUF | valid | [clm_9510E2610E38](/claim/clm_9510E2610E38.md)
- 2026-04-20 | other | hf_repo_created | ibm-granite/granite-embedding-311m-multilingual-r2 | valid | [clm_222A1C66D842](/claim/clm_222A1C66D842.md)
- 2026-04-20 | other | hf_repo_created | ibm-granite/granite-embedding-97m-multilingual-r2 | valid | [clm_30F99FC99F65](/claim/clm_30F99FC99F65.md)
- 2026-04-20 | other | hf_repo_created | ibm-granite/granite-4.1-3b-fp8 | valid | [clm_4CBA7DCF79D1](/claim/clm_4CBA7DCF79D1.md)
- 2026-04-20 | other | hf_repo_created | ibm-granite/granite-4.1-30b-fp8 | valid | [clm_6D7340A47892](/claim/clm_6D7340A47892.md)
- 2026-04-20 | other | hf_repo_created | ibm-granite/granite-4.1-8b-fp8 | valid | [clm_6F69C883A4F9](/claim/clm_6F69C883A4F9.md)
- 2026-05-01 | other | hf_repo_created | ibm-granite/granite-switch-4.1-3b-preview | valid | [clm_7736C52BED17](/claim/clm_7736C52BED17.md)
- 2026-05-01 | other | hf_repo_created | ibm-granite/granite-switch-4.1-30b-preview | valid | [clm_9B267207436F](/claim/clm_9B267207436F.md)
- 2026-05-01 | other | hf_repo_created | ibm-granite/granite-switch-4.1-8b-preview | valid | [clm_EF2A00CF14D0](/claim/clm_EF2A00CF14D0.md)
- 2026-05-11 | other | hf_repo_created | ibm-granite/granite-speech-4.1-2b-GGUF | valid | [clm_3E700CC58BC9](/claim/clm_3E700CC58BC9.md)
- 2026-05-11 | other | hf_repo_created | ibm-granite/granite-4.0-1b-speech-GGUF | valid | [clm_DD896B11BE90](/claim/clm_DD896B11BE90.md)
- 2026-05-14 | products | released | Granite Embedding Multilingual R2 | unverified | [clm_BD80EA00E31D](/claim/clm_BD80EA00E31D.md)
- 2026-05-21 | other | hf_repo_created | ibm-granite/granite-timeseries-ttm-r3 | valid | [clm_6C7E453C2321](/claim/clm_6C7E453C2321.md)
- 2026-05-26 | other | hf_repo_created | ibm-granite/granite-guardian-4.1-8b-GGUF | valid | [clm_14812AAAAFD6](/claim/clm_14812AAAAFD6.md)
- 2026-06-18 | other | hf_repo_created | ibm-granite/granite-vision-4.1-4b-GGUF | valid | [clm_85F585D7BEAE](/claim/clm_85F585D7BEAE.md)
- 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 7,172,000,000 United States dollar | superseded | [clm_2BEAF894F936](/claim/clm_2BEAF894F936.md)
- 2026-06-30 | other | hf_repo_created | ibm-granite/granite-speech-4.1-2b-plus-GGUF | valid | [clm_FCB51D7952C8](/claim/clm_FCB51D7952C8.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_net_income | 2,165,000,000 United States dollar | superseded | [clm_8AC2DB370EC0](/claim/clm_8AC2DB370EC0.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_research_and_development | 2,311,000,000 United States dollar | superseded | [clm_7AAD89ECE446](/claim/clm_7AAD89ECE446.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 17,162,000,000 United States dollar | superseded | [clm_F72D29981106](/claim/clm_F72D29981106.md)
- 2026-06-30 to 2026-09-30 | money | shares_outstanding | 942,134,390 shares | superseded | [clm_234BA0DBBC73](/claim/clm_234BA0DBBC73.md)
- 2026-06-30 to 2026-09-30 | money | total_assets | 152,099,000,000 United States dollar | superseded | [clm_9AAB8394D3EF](/claim/clm_9AAB8394D3EF.md)
- 2026-06-30 to 2026-09-30 | money | total_equity | 34,452,000,000 United States dollar | superseded | [clm_211AB165349F](/claim/clm_211AB165349F.md)
- 2026-07-01 | other | hf_repo_created | ibm-granite/granite-swash-2b | valid | [clm_6BB857730B63](/claim/clm_6BB857730B63.md)
- 2026-07-01 | other | hf_repo_created | ibm-granite/granite-swash-3b-a600m | valid | [clm_C62B022184DD](/claim/clm_C62B022184DD.md)
- 2026-08-04 | other | hf_repo_created | ibm-granite/granite-speech-5.0-470m-turboctc | valid | [clm_08A82CFB863C](/claim/clm_08A82CFB863C.md)
- 2026-08-07 | other | hf_repo_created | ibm-granite/granite-4.2-8b | valid | [clm_1084B921CBCD](/claim/clm_1084B921CBCD.md)
- 2026-08-07 | other | hf_repo_created | ibm-granite/granite-4.2-30b | valid | [clm_6C84E4EFEEF6](/claim/clm_6C84E4EFEEF6.md)
- 2026-08-07 | other | hf_repo_created | ibm-granite/granite-4.2-3b | valid | [clm_E2E380DBE34E](/claim/clm_E2E380DBE34E.md)
- 2026-08-07 | other | hf_repo_created | ibm-granite/granite-timeseries-patchtst-fm-r2 | valid | [clm_EA71E1CC5917](/claim/clm_EA71E1CC5917.md)
- 2026-08-12 | other | hf_repo_created | ibm-granite/granite-4.2-8b-GGUF | valid | [clm_08D146684C5F](/claim/clm_08D146684C5F.md)
- 2026-08-12 | other | hf_repo_created | ibm-granite/granite-4.2-30b-GGUF | valid | [clm_A6CF385D9BB2](/claim/clm_A6CF385D9BB2.md)
- 2026-08-12 | other | hf_repo_created | ibm-granite/granite-4.2-3b-GGUF | valid | [clm_D604C1383A62](/claim/clm_D604C1383A62.md)
- 2026-08-13 | other | hf_repo_created | ibm-granite/granite-4.2-8b-nvfp4 | valid | [clm_0E2B0A884672](/claim/clm_0E2B0A884672.md)
- 2026-08-13 | other | hf_repo_created | ibm-granite/granite-4.2-3b-fp8 | valid | [clm_0FC743F14D3F](/claim/clm_0FC743F14D3F.md)
- 2026-08-13 | other | hf_repo_created | ibm-granite/granite-4.2-30b-mxfp4 | valid | [clm_1E2FE6113920](/claim/clm_1E2FE6113920.md)
- 2026-08-13 | other | hf_repo_created | ibm-granite/granite-4.2-3b-nvfp4 | valid | [clm_2572A54158DD](/claim/clm_2572A54158DD.md)
- 2026-08-13 | other | hf_repo_created | ibm-granite/granite-4.2-8b-fp8 | valid | [clm_60A193958366](/claim/clm_60A193958366.md)
- 2026-08-13 | other | hf_repo_created | ibm-granite/granite-4.2-30b-nvfp4 | valid | [clm_9A563538CFA8](/claim/clm_9A563538CFA8.md)
- 2026-08-13 | other | hf_repo_created | ibm-granite/granite-4.2-3b-mxfp4 | valid | [clm_BC1911215D3E](/claim/clm_BC1911215D3E.md)
- 2026-08-13 | other | hf_repo_created | ibm-granite/granite-4.2-30b-fp8 | valid | [clm_CE82C8D2C9B5](/claim/clm_CE82C8D2C9B5.md)
- 2026-08-13 | other | hf_repo_created | ibm-granite/granite-4.2-8b-mxfp4 | valid | [clm_E616A27AEAA8](/claim/clm_E616A27AEAA8.md)
- 2026-08-17 | other | hf_repo_created | ibm-granite/granite-speech-5.0-470m-turboctc-nc | valid | [clm_023D5FE5E58A](/claim/clm_023D5FE5E58A.md)
- 2026-09-01 | other | hf_repo_created | ibm-granite/granite-4.2-3b-q8-mlx | valid | [clm_2108BF20248C](/claim/clm_2108BF20248C.md)
- 2026-09-01 | other | hf_repo_created | ibm-granite/granite-4.2-3b-q4-mlx | valid | [clm_33BB70B1BD57](/claim/clm_33BB70B1BD57.md)
- 2026-09-01 | other | hf_repo_created | ibm-granite/granite-4.2-30b-q4-mlx | valid | [clm_487A314495BB](/claim/clm_487A314495BB.md)
- 2026-09-01 | other | hf_repo_created | ibm-granite/granite-4.2-8b-bf16-mlx | valid | [clm_489101A50C11](/claim/clm_489101A50C11.md)
- 2026-09-01 | other | hf_repo_created | ibm-granite/granite-4.2-8b-q4-mlx | valid | [clm_9EFFA984C301](/claim/clm_9EFFA984C301.md)
- 2026-09-01 | other | hf_repo_created | ibm-granite/granite-4.2-8b-q8-mlx | valid | [clm_A69FD06B5241](/claim/clm_A69FD06B5241.md)
- 2026-09-01 | other | hf_repo_created | ibm-granite/granite-4.2-30b-bf16-mlx | valid | [clm_B6FB0BE7018B](/claim/clm_B6FB0BE7018B.md)
- 2026-09-01 | other | hf_repo_created | ibm-granite/granite-4.2-3b-bf16-mlx | valid | [clm_B9F0AC27AB51](/claim/clm_B9F0AC27AB51.md)
- 2026-09-01 | other | hf_repo_created | ibm-granite/granite-4.2-30b-q8-mlx | valid | [clm_EE5AFC9F147E](/claim/clm_EE5AFC9F147E.md)
- 2026-09-23 | other | hf_repo_created | ibm-granite/granite-timeseries-ensemble-r1 | valid | [clm_4E84389C61B0](/claim/clm_4E84389C61B0.md)
- 2026-09-30 | money | cash_and_equivalents | 9,233,000,000 United States dollar | valid | [clm_80746B27404A](/claim/clm_80746B27404A.md)
- 2026-09-30 | money | quarterly_net_income | 2,190,000,000 United States dollar | valid | [clm_85804F4F3BE7](/claim/clm_85804F4F3BE7.md)
- 2026-09-30 | money | quarterly_research_and_development | 2,378,000,000 United States dollar | valid | [clm_6EF7FFE10AC3](/claim/clm_6EF7FFE10AC3.md)
- 2026-09-30 | money | quarterly_revenue | 17,103,000,000 United States dollar | valid | [clm_23B9298FFE34](/claim/clm_23B9298FFE34.md)
- 2026-09-30 | money | shares_outstanding | 945,120,805 shares | valid | [clm_ADCAB89FF391](/claim/clm_ADCAB89FF391.md)
- 2026-09-30 | money | total_assets | 155,011,000,000 United States dollar | valid | [clm_C08AE095383F](/claim/clm_C08AE095383F.md)
- 2026-09-30 | money | total_equity | 35,537,000,000 United States dollar | valid | [clm_C2AF607185AB](/claim/clm_C2AF607185AB.md)
- 2026-10-01 | people | board_member | Frank Baker | valid | [clm_1D3EE387A5AA](/claim/clm_1D3EE387A5AA.md)
- 2026-10-01 | other | hf_repo_created | ibm-granite/ensemble-forecasting-with-ibm-granite-time-series | valid | [clm_D869CEAC7A56](/claim/clm_D869CEAC7A56.md)
- 2026-10-07 | other | hf_repo_created | ibm-granite/granite-speech-5.0-2b | valid | [clm_D8861C9F62E6](/claim/clm_D8861C9F62E6.md)
- 2026-10-14 | other | hf_repo_created | ibm-granite/granite-switch-4.1-8b | valid | [clm_8F6C9ECD70FD](/claim/clm_8F6C9ECD70FD.md)
- 2026-10-14 | other | hf_repo_created | ibm-granite/granite-switch-4.1-30b | valid | [clm_CEE7CD9E5ACD](/claim/clm_CEE7CD9E5ACD.md)
- 2026-10-14 | other | hf_repo_created | ibm-granite/granite-speech-5.0-2b-GGUF | valid | [clm_ECF2C0E3CD60](/claim/clm_ECF2C0E3CD60.md)
- 2026-10-22 | other | hf_repo_created | ibm-granite/granite-switch-4.1-30b-GGUF | valid | [clm_A95613377E24](/claim/clm_A95613377E24.md)
- 2026-10-22 | other | hf_repo_created | ibm-granite/granite-switch-4.1-8b-GGUF | valid | [clm_AAAFC50D90A5](/claim/clm_AAAFC50D90A5.md)
- 2026-10-28 | other | hf_repo_created | ibm-granite/granite-speech-5.0-2b-ONNX | valid | [clm_FEBB5E642AD7](/claim/clm_FEBB5E642AD7.md)
- 2026-10-28 | money | market_cap | 236,500,000,000 United States dollar | valid | [clm_FB4C21B3DAD6](/claim/clm_FB4C21B3DAD6.md)
- 2026-10-28 | money | partnership | USTA | valid | [clm_DC51D21416EC](/claim/clm_DC51D21416EC.md)
- 2026-10-29 | products | released | Granite Switch 4.1.1 | unverified | [clm_296B39C0C860](/claim/clm_296B39C0C860.md)
- 2026-11-05 | money | partnership | [AMD](/record/amd.md) | valid | [clm_A3D35B4B17B6](/claim/clm_A3D35B4B17B6.md)
- 2026-11-06 | products | launched | IBM Quantum System Two | valid | [clm_95C9475D0F13](/claim/clm_95C9475D0F13.md)

## undated

- undated | other | cik | 0000051143 | valid | [clm_41F270CB4CA5](/claim/clm_41F270CB4CA5.md)
- undated | other | fiscal_year_end | 12-31 | valid | [clm_A67713C11655](/claim/clm_A67713C11655.md)
- undated | other | headquarters | Armonk | valid | [clm_7801233D8138](/claim/clm_7801233D8138.md)
- undated | other | listed_on | NYSE | valid | [clm_A14BE905EEEF](/claim/clm_A14BE905EEEF.md)
- undated | other | registrant_name | INTERNATIONAL BUSINESS MACHINES CORP | valid | [clm_DF34B724E332](/claim/clm_DF34B724E332.md)
- undated | other | sic_industry | Computer & office Equipment (3570) | valid | [clm_C7D817240C7C](/claim/clm_C7D817240C7C.md)
- undated | other | state_of_incorporation | NY | valid | [clm_E1F1A7F354D4](/claim/clm_E1F1A7F354D4.md)
- undated | other | ticker | IBM | valid | [clm_8EE04970B8DA](/claim/clm_8EE04970B8DA.md)
- undated | other | country | United States | valid | [clm_07A96E3B5324](/claim/clm_07A96E3B5324.md)
- undated | people | founder | Charles Ranlett Flint | valid | [clm_AEEA758C2F51](/claim/clm_AEEA758C2F51.md)
- undated | other | subsidiary | IBM India Private Limited | valid | [clm_151BDABD6F83](/claim/clm_151BDABD6F83.md)
- undated | other | subsidiary | IBM Canada | valid | [clm_4F1F3576740A](/claim/clm_4F1F3576740A.md)
- undated | other | subsidiary | IBM France | valid | [clm_610B139CE762](/claim/clm_610B139CE762.md)
- undated | other | subsidiary | IBM Nederland | valid | [clm_BEAAC92FF254](/claim/clm_BEAAC92FF254.md)
- undated | other | subsidiary | SoftLayer | valid | [clm_DDCF0DFFD0D2](/claim/clm_DDCF0DFFD0D2.md)
- undated | other | subsidiary | IBM Egypt Business Support Services | valid | [clm_E08E001857C3](/claim/clm_E08E001857C3.md)
- undated | other | subsidiary | Companhia IBM Portuguesa | valid | [clm_F396DAA98FA9](/claim/clm_F396DAA98FA9.md)
- undated | other | website | https://www.ibm.com/de-de/ | valid | [clm_25ACB7ACF6E9](/claim/clm_25ACB7ACF6E9.md)
- undated | other | website | https://www.ibm.com/uk-en | unverified | [clm_A3C36EF4A31F](/claim/clm_A3C36EF4A31F.md)
- undated | other | website | https://www.ibm.com/us-en/ | unverified | [clm_C626AFB08D79](/claim/clm_C626AFB08D79.md)
- undated | other | website | https://www.ibm.com/ | unverified | [clm_F83E4987E2D5](/claim/clm_F83E4987E2D5.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.